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Abstract
The reconstruction of regulatory networks is one of the most challenging tasks in
systems biology. Although some models for inferring regulatory networks can make
useful predictions about the wiring and mechanisms of molecular interactions, these
approaches are still limited and there is a strong need to develop increasingly univer-
sal and accurate approaches for network reconstruction. This problem is particularly
challenging in mammals, due to the higher complexity of mammalian regulatory net-
works and limitations in experimental manipulation. In this thesis, I present three
systematic approachs to reconstruct, analyse and refine models of gene regulation.
In Chapter 1, I devise a method for deriving an observational model from temporal
genomic profiles. I use it to choose targets for perturbation experiments in order to
determine a network controlling the responses of mouse primary dendritic cells to
stimulation with pathogen components. In Chapter 2, I introduce the algorithm Exi-
go, for identifying essential interactions in regulatory networks reconstructed from
experimental data where regulators have been silenced, using a network reduction
strategy. Exigo outperforms previous approaches on simulated data, uncovers the
core network structure when applied to real networks derived from perturbation stu-
dies in mammals, and improves the performance of network inference methods. Lastly,
I introduce in Chapter 3 an approach to learn a module network from multiple high-
throughput assays. Analysis of a diffuse large B-cell lymphoma dataset identifies
candidate regulator genes, microRNAs and copy number aberrations with biological,
and possibly therapeutic, importance.
Thesis Supervisor: Aviv Regev, Ph.D.
Title: Associate Professor of Biology
5
6
Acknowledgments
First and foremost, I would like to express my deepest gratitude to my advisor, Pro-
fessor Aviv Regev, for welcoming me into her lab and sharing with me her experience,
knowledge and insights (Aviv, I hope to make you proud in my future research en-
deavors). Second, I'd like to express tremendous gratitude to my thesis committee,
Professors Bonnie Berger and Ernest Fraenkel, for sharing with me their time and
knowledge, listening to my ideas, and pointing me in helpful directions. I am also
thankful to Professor Chris Burge for his guidance and support.
This journey started at Instituto Gulbenkian de Ci~ncia, in the context of its
pioneering PhD Program in Computational Biology. In this regard, I am thankful
to Marie-France Sagot and Jorge Carneiro for their mentorship. I must also thank
Fundacio para a Ci~ncia e a Tecnologia for funding my work.
I want to thank all past and present members of the Regev lab for the good
working atmosphere and the scientific - and sometimes not so scientific - discussions.
In particular, I want to thank Dawn, Ilan and Noa, for being so helpful when I joined
the lab; Sushmita and Alon for sharing with me their knowledge and experience;
Kendra for all her dedication; and Jay, Jenna, Courtney, Michelle, Jason and Nathalie
for all the joyful time together. The work in this thesis would not have been possible
without collaborations with Ido, Max and Stefano, who taught me how science can
be fun.
On a personal note, I want to acknowledge my Portuguese friends. Special thanks
go to Joana, Claudia, Paulinha, Ana Sofia, Ligia, Garfo, Truta, Ana Rita, Ana Luisa,
Isis, Sandra, Silvia, Victor, Paula and Z6, but there are many more. Your friendship
is truly a blessing. Also, I have no words to describe how thankful I am to Elsa,
Francisco and David. I will always remember the moments we have shared together.
I have saved the most important acknowledgements for last. I owe everything that
I am to my parents, Ana Maria and Joio. Their support has been unsurpassable and
unflagging, their love unbounded and unconditional. Finally, my husband Rogerio
has simply been the greatest person I've ever met.
7
8
Contents
1 Introduction 13
1.1 O verview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.2 Regulatory network reconstruction . . . . . . . . . . . . . . . . . . . 14
1.3 Heterogeneous models capture regulatory circuitry at several levels . . 20
2 Reconstruction of a Mammalian Transcriptional Network Mediating
Pathogen Responses 25
2.1 A bstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2.2 B ackground . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.3 Profiling of mRNA levels . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.4 Detection of response specific genes . . . . . . . . . . . . . . . . . . . 28
2.5 Reconstruction of an observational trans-model of gene regulation . . 29
2.6 Selection of candidate regulators for perturbation and a response sig-
nature .......... ................................... 34
2.7 Perturbation experiments and network reconstruction . . . . . . . . . 36
2.8 Comparison between the observational and the perturbation model 37
2.9 D iscussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.10 M aterials and methods . . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.11 F igures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3 Systematic identification of topologically essential interactions in
regulatory networks 65
3.1 A bstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
9
Background . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
R esults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82
Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . . 84
Figures and tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
4 Inferring transcriptional and microRNA-mediated regulatory pro-
grams in Diffuse Large B-cell Lymphoma
4.1 A bstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.2 Background . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.3 Learning of a Module Network for DLBCL . . . . . . . . . .
4.4 Modules are enriched for specific processes and functions . .
4.5 Regulatory programs overview . . . . . . . . . . . . . . . . .
4.6 Potential regulators with a role in DLBCL . . . . . . . . . .
4.7 Regulators associated with survival and "consensus cluster"
4.8 Association between copy number aberrations and modules
4.9 Design of experimental validation of biological findings . . .
4.10 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.11 Figures and tables . . . . . . . . . . . . . . . . . . . . . . .
105
. . . . . 105
. . . . . 106
. . . . . 108
. . . . . 110
. . . . . 111
. . . . . 112
. .. . 115
. . . . . 117
. . . . . 118
. . . . . 119
. . . . . 120
5 Conclusions
5.1 Sum m ary ....... .. .. ............ ....... ....
5.2 Future perspectives . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Bibliography
135
135
137
141
10
3.2
3.3
3.4
3.5
3.6
Chapter 1
Introduction
12
Chapter 1
Introduction
1.1 Overview
The reconstruction of regulatory networks is one of the most challenging tasks in
systems biology. Although some models for inferring regulatory networks can make
useful predictions about the wiring and mechanisms of molecular interactions, these
approaches are still limited and there is a strong need to develop increasingly univer-
sal and accurate approaches for network reconstruction. This problem is particularly
challenging in mammals, due to the higher complexity of mammalian regulatory net-
works and limitations in experimental manipulation.
In this thesis, I present a broadly-applicable approach to reconstruct, analyze
and refine models of gene regulation. In Chapter 1, I introduce existing approaches
and their limitations. In Chapter 2, I devise a method for deriving an observational
model from genome-wide temporal expression profiles and use it to choose targets
for perturbation experiments, in a study of the network controlling the response of
Dendritic Cells (DCs) to stimulation with pathogen components. In Chapter 3, I
develop an algorithm for distinguishing relevant from irrelevant interactions in the
perturbation network and to refine the initial model. In Chapter 4, 1 reconstruct and
analyse an integrative regulatory model of Diffuse Large B-Cell Lymphoma (DLBCL)
and use it to suggest perturbation experiments. I conclude this thesis in Chapter 5
with a summary of the chapters and a discussion of future work.
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1.2 Regulatory network reconstruction
Regulatory networks are the information processing devices of cells, transforming cel-
lular signals into coherent transcriptional responses. However, even for well character-
ized systems we do not fully understand how a regulatory network processes signals,
encodes the relevant information at different layers of the network, and achieves the
fine-tuned change in expression in each target gene. In particular, reconstruction of
regulatory networks in mammalian cells has been a challenge [1], given the system
complexity and the obstacle of performing targeted genetic perturbations on a large
scale in a mammalian animal model.
There are three main approaches to reconstruct regulatory networks: (1) obser-
vational models look for statistical associations between regulatory elements (in pro-
moter sequences [2]) or factors (in mRNA expression [3]) and target gene expression;
(2) perturbational models examine the effect of genetic perturbation (deletion [4],
overexpression [5], knockdown [6], or natural genetic variation [7]) on gene expres-
sion; and (3) physical models examine direct binding between regulatory proteins and
promoters or enhancers. In many cases, heterogeneous models attempt to integrate
one or more of these approaches.
Inferring regulation from observational models
Two major 'observational' strategies have been used to associate regulators with
putative targets on a genome scale [8]: (1) cis-regulatory models, which consider
the presence of predicted transcription factor (TF) binding sites in the promoters of
target genes [1, 8]; and (2) trans-regulatory models, that infer interactions based on
correlations between regulator and target expression [1, 3, 8]. The latter approach
relies on the fact that many trans-regulators are embedded within transcriptional
feedback and feedforward regulatory loops [3, 9], and hence their own expression
may be transcriptionally regulated within processes that they control. These two
types of models have some inherent limitations. In particular, cis-regulatory models
cannot predict expression because they are not condition specific, and trans-regulatory
14
models only account for changes in mRNA levels, not activity. It is, though, still
challenging to estimate the success of most of the models. Two major reasons for
this are the lack of systematic experimental follow-up and the limited scale of most
datasets. It is thus important to establish standard methodologies and data sets on
which the performance of different models can be compared.
Module-based algorithms
Many of the observational models developed rely on the assumption that gene mo-
dules (rather than individual genes) are the units of gene regulation. The rationale
for this grouping is based on several examples in which the same regulatory circuits
coordinate activation or repression of a regulon of genes that are involved in the
same process (e.g., all ribosomal protein genes are regulated by common transcri-
ption factors). Module-based models have been extensively used in genomics ([3, 10])
because they achieve greater statistical power by using fewer parameters.
Module Networks algorithm
Module Networks [3] is a procedure based on probabilistic graphical models [11]. It
takes as input a data set of gene expression profiles and a large precompiled set of
candidate regulator genes, and determines both the partition of genes to modules and
the regulatory programs, that explain the behavior of the genes in the modules as a
function of the expression level of sets of regulators (Fig. 1-1).
In Module Networks, the action of regulators on each module is described by a
logical program represented as a decision tree . Each node in the tree consists of
a regulatory gene and each leaf of a regulation context, that is, a configuration of
the regulator genes, determined by the path from the root to the leaf. A regulation
context determines the gene expression probabilistically. For example, in Fig. 1-1,
when regulator gene A is downregulated and regulator gene B is upregulated, the
module genes are repressed.
A module network is learned by both partitioning the genes into modules and
learning the Bayesian network between the module nodes. This is accomplished
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using an Expectation-Maximization (EM) algorithm. In the M-step, it learns the
best decision tree for each module, given the partition of genes into modules. In other
words, given the module assignments, the algorithm builds the regulatory program
for each module by choosing the regulator whose split best predicts the behavior
of the module genes, creating a node on the decision tree for this regulator and
then recursing on the two branches. In the E-step, the gene pool is partitioned into
modules, given the regulatory programs. Basically, for each gene in a module, we can
obtain a probability value that a gene expression value was obtained by a particular
regulatory program. In this case, the algorithm simply assigns the gene to the module
that best predicts it. Each reassignment therefore is guaranteed to improve the overall
predictiveness.
The Module Networks algorithm has been applied to yeast [3] and mammals [12],
showing its ability to make reasonable predictions and to provide a deeper under-
standing of the functionality of a regulatory network. By pooling many similar genes
together, the module network framework significantly increases the statistical power
to identify regulatory influences. For that reason, it has inspired the development of
other algorithms. For example, Segal et al. [13] present a probabilistic model over
both gene expression and sequence data to identify transcriptional modules and the
regulatory motif binding sites that control their regulation within a given set of ex-
periments; Geronemo [14] automatically constructs a set of co-regulated genes whose
regulation can involve both sequence variations and expression of regulators; LIRNET
[15] solves a SNP-eQTL module network involving sequence variations, expression of
regulators and prior knowledge; and CONEXIC [16] integrates matched copy num-
ber (amplifications and deletions) and gene expression data from tumor samples to
identify driving mutations and the processes they influence.
Linear regression models
Linear regression models have provided a robust alternative to module-based algo-
rithms as observational models [17]. In a multiple linear regression, the objective is
to find weights or regression coefficients for the independent variables such that the
16
linear combination explains the variance of the dependent variable as well as possible.
The weights describe the relative importance of each independent variable.
Linear regression models have been applied to learn both cis-regulatory models
[18], by modelling gene expression as a function of one or more known or potential
transcription factor binding site variables based on the gene's regulatory region (e.g.
motif counts, position weight matrix (PWM) scores, ChIP-chip quantities), or trans-
regulatory models of gene regulation [19], by modelling target gene expression as a
combination of TFs expression levels.
High dimensionality of microarray data can lead to models that are very complex
and pose challenges in prediction and interpretation. For this reason, penalized re-
gression methods have received much attention over the past few years, as a proper
way to get sparse models. The use of penalties facilitate fitting models with predic-
tors that run into thousands, including many irrelevant to the response, far exceed
the sample size, or are highly correlated. Three regularized linear regression mo-
dels often used in genomic studies (e.g. [15]) are ridge regression [20], least absolute
shrinkage and selection operator (LASSO) [21], and elastic net [22]. The ridge re-
gression uses a L2 penalty and is best used when there are high correlations between
predictors. However, it could be influenced by irrelevant variables since it uses all
the predictors in hand. The LASSO uses the L1 penalty and does both continuous
shrinkage and automatic variable selection simultaneously. However, in the presence
of multicollinearity, it has empirically been observed that the prediction performance
of the LASSO is dominated by ridge regression [21]. Elastic net attempts to keep
the advantages of both ridge and LASSO, overcoming their limitations by combining
the L1 and L 2 penalties. In addition, it has a grouping effect, i.e., if there is a set of
variables among which the pairwise correlations are high, the elastic net groups the
correlated variables together.
Reconstructing models from temporal data
Biological systems are predominantly dynamic [23] and analysis of temporal gene
expression profiles can provide valuable insights about a system. For this reason,
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systems' dynamics over a period of time have been investigated in computational
modeling of cellular processes [24, 25].
Different methods have been extensively explored to infer causal relationships
from time series gene expression data, such as ordinary differential equations [26],
dynamic bayesian networks [27], Granger causality [28], Hidden Markov Models [29]
and mutual information approaches [30]. However, these expression-based inference
methods have had only limited success for several reasons: (1) the insufficient time
resolution of the available samples often limit our ability to distinguish signal from
noise and results in fast responses being missed; (2) it is hard to distinguish between
regulators that actually regulate a gene (i.e., that have a direct causal effect) and
regulators that are merely co-expressed with a gene; and (3) some methods lack a
systematic way to determine a biologically relevant transcriptional time lag, which
may be due to the combined effects of the translation, folding, nuclear translocation
and turnover time-scales for the regulatory protein and for elongation of the target
gene mRNA. Not modeling the time that it takes for the regulator gene to express
its protein product and the transcription of the target gene to be affected by this
regulator protein prevents from capturing expression dynamics and may result in low
accuracy.
Perturbational models can uncover cellular wiring diagrams
Perturbational models associate targets to factors based on the effect of the factors'
genetic manipulation on gene expression. Recent advances in genomics technology,
such as mRNA profiling and the development of genome-scale lentiviral RNA inter-
ference (RNAi) for efficient perturbation, make it possible to reconstruct complex
circuits. For example, Baym et al. [31] present a technique to infer the Rho-signaling
network in Drosophila from microarray data on perturbation experiments.
Systematic perturbation experiments can be important for validating the regu-
latory interactions predicted by an observational (non-perturbational) model. Such
experiments have been successfully employed in modeling regulatory networks in sea
urchin [32] and yeast [33], calling for new computational strategies. In particular,
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effective ways to distinguish the indirect effects of a perturbation from the direct ef-
fects, since many of the network interactions, identified by gene knockdown instead
of by direct measurements of transcription factor-promoter binding, are likely to be
indirect.
A starting point to distinguish direct from indirect effects has been proposed
by Wagner [34-36]. This approach uses gene perturbation experiments to build a
directed graph (perturbation graph), where an edge is introduced from gene A to
gene B if perturbing A results in a significant expression change in B. It then uses
graph-theoretic methods of transitive reduction [37] to reconstruct the minimal (most
parsimonious) subgraph. However, this approach presents several limitations, such
as radical pruning and the pre-requisite that the perturbation graph is acyclic. To
overcome these issues, several other strategies have followed [38-40], but they are
generally computationally expensive and fail to take into account the effect of indirect
interactions while globally explaining the experimental data. These approaches are
extensively discussed in Chapter 3.
Accurate computational methods to analyze perturbation graphs are essential in a
time when RNAi screening is becoming part of the standard experimental repertoire.
In the future, RNAi screens will only be the first step in the comprehensive analysis
of biological phenomena. Iteratively integrating experimentation and computation is
a promising approach to refine our understanding of the inner working of the cell.
Physical models examine direct binding
Physical models associate regulatory factors with the targets whose promoters they
bind [41, 42]. Indeed, chromatin immunoprecipitation (ChIP) has revolutionized the
study of transcriptional networks: maps of TF-DNA binding can be coupled with
measurements of expression output to build models of regulatory circuits [8]. Even
though binding information should be interpreted with caution, as the presence of
a regulator at a promoter region binding does not necessarily mean functional regu-
lation, measurement of TF binding before and after a stimulus can help distinguish
between direct and indirect targets [33, 42, 43].
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Measurements of trans inputs are still limited by the effort and cost in genera-
ting the needed reagents and data, such as the development of an epitope-tagged
version of every TF and the large amounts of material required in large-scale screens.
Automated methods for systematic mapping TFs, that increase the throughput and
sensitivity, while reducing the labor and cost for ChIP experiments, can assist in
further understanding mammalian regulatory circuits across a range of cell states,
conditions and perturbations.
1.3 Heterogeneous models capture regulatory cir-
cuitry at several levels
Biological systems employ heterogeneous regulatory mechanisms that are frequently
intertwined. Recent technological advances have made available several types of ge-
nomic and proteomic data, some already mentioned above. Among them are miRNA
and gene expression, copy number aberrations (CNAs), single nucleotide polymor-
phisms (SNPs), and protein-protein/gene-gene interactions. Each of these data types
provides a different, partly independent and complementary, view of the whole cir-
cuit. However, understanding functions of genes, proteins, and other components of
the genome requires more information than provided by each of the datasets. For
example, Huang et al. [44] derive a network of protein-protein and protein-DNA in-
teractions that explains the functional context of genes and proteins detected in these
assays and uncovers diverse pathways not obvious from the input.
Integrating data from different sources can bring many challenges. Genomic data
arise in the form of vectors, graphs, or sequences, and it is important to carefully
consider strategies that best capture the most information contained in each data.
Moreover, data from different sources might have different quality and informativity.
For example, probe design and experimental conditions are known to influence signal
intensities and sensitivities for many high-throughput technologies.
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Data integration in clinical setting
The need for integration of heterogeneous data measured on the same individuals
arises in a wide range of clinical applications. In this regard, the best example is
perhaps the challenge that cancer researchers and clinicians face in the diagnosis,
treatment, and prognosis of this complex disease. Cancer is thought to be prima-
rily caused by genetic alterations and, as such, genomic data like gene expression
and CNAs can be used together to develop models that learn novel regulation func-
tions [45]. The critical challenge is in differentiating between alterations that drive
the cancer growth and other seemingly random alterations that accumulate through
instability induced by tumorigenesis. For example, the CONEXIC algorithm [16]
combines DNA copy number with gene expression levels to identify driver mutations
and predict the processes that they alter. The model assumes that a driver mutation
should co-vary with a gene module involved in tumorigenesis (i.e., it assumes that
the modules expression is "modulated" by the driver), and that expression levels of
the driver control the malignant phenotype rather than copy number (because other
mechanisms may lead to similar dysregulated expression of the driver gene). This
approach predicted two new tumor dependencies in melanoma and the processes that
they alter. Other studies tracked the causes of abnormal gene expressions by corre-
lating them with gene mutations, DNA methylations or microRNA expressions (e.g.,
[46, 47]). However, integrative studies are often restricted to pairwise comparisons
between two types of data and lack a unifying framework to integrate multiple types
of data in the same model.
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Figure
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Figure 1-1: Overview of the module networks algorithm. The procedure takes as
input a data set of gene expression profiles and a pre-compiled set of candidate regulator
genes. The method itself (dashed box) is an iterative procedure that determines both the
partition of genes to modules and the regulatory program (below the dashed box) for each
module. Red/Blue - high/low expression. Figure adapted from [3].
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Chapter 2
Unbiased Reconstruction of a
Mammalian Transcriptional
Network Mediating Pathogen
Responses
Part of the work included in this chapter was first published as:
Ido Amit, Manuel Garber*, Nicolas Chevrier*, Ana Paula Leite*, Yoni Donner*,
Thomas Eisenhaure, Mitchell Guttman, Jennifer K. Grenier, Weibo Li, Or Zuk, Lisa
A. Schubert, Brian Birditt, Tal Shay, Alon Goren, Xiaolan Zhang, Zachary Smith,
Raquel Deering, Rebecca C. McDonald, Moran Cabili, Bradley E. Bernstein, John
L. Rinn, Alex Meissner, David E. Root, Nir Hacohen, and Aviv Regev. Unbiased
Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Re-
sponses. Science, 2009;326(5950):257-63. PMID: 19729616. * These authors con-
tributed equally to this work.
Experiments in this chapter were performed by Ido Amit and Nicolas Chevrier in the
Regev and Hacohen laboratories. Yoni Donner developed GeneSelector and Manuel
Garber colaborated in nCounter data analysis.
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Chapter 2
Reconstruction of a Mammalian
Transcriptional Network Mediating
Pathogen Responses
2.1 Abstract
Deciphering the regulatory networks that control dynamic and specific gene expres-
sion responses in mammalian cells remains a major challenge. While models inferred
from genomic data have identified candidate regulatory mechanisms, such models
remain largely unvalidated. Here, we built on the framework of graphical models
and Elastic-Net regression to learn an observational model of gene regulation from
temporal expression profiles. We used it to identify candidate regulators that act on
target genes in the transcriptional response to pathogens in primary Dendritic Cells
(DCs). We then tested the regulatory function of 125 of the candidate regulators
(consisting of transcription factors, chromatin modifiers, and RNA binding proteins)
by systematic perturbions with shRNAs, followed by measurement of a gene expres-
sion signature during response to the same pathogen components. This approach
accurately assigned 32 known regulators (e.g. NFB, IRFs, and STATs) to their tar-
get genes and discovered 68 additional functional regulators that were not previously
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implicated in this response. This unique dataset provided a valuable resource to es-
timate the quality of the observational model. We observed that it identified many
correct regulators but revealed numerous false positive relations, confirming that in-
ferring regulatory activity from expression levels alone limits the model's ability to
distinguish between causality and correlation. Generally, this study establishes a
broadly-applicable, comprehensive and unbiased approach to identifying the wiring
and function of a regulatory network controlling a major transcriptional response in
primary mammalian cells.
2.2 Background
Regulatory networks controlling gene expression serve as decision-making circuits
within cells. For example, when immune dendritic cells (DCs) are exposed to viruses,
bacteria, or fungi, they respond with transcriptional programs that are specific to each
pathogen [48] and are essential for establishing appropriate immunological outcomes
[49]. These fast and dynamic responses are initiated through specific receptors, such
as Toll-like receptors (TLRs), that distinguish broad pathogen classes and are prop-
agated through well-characterized signaling cascades [49]. However, little is known
about how the transcriptional network is wired to produce specific outputs.
Systematic unbiased reconstruction of regulatory networks in any mammalian cell
remains a fundamental challenge. Two major strategies have been previously used to
associate regulators with their putative targets on a genome scale [8]: cis-regulatory
models rely on the presence of predicted binding sites for a factor in the promoters
of target genes [1, 8, 50], whereas trans-regulatory models rely on the dependence
between the activity of expression of a regulator to that of its targets across samples
[1, 3, 8, 50]. In innate immunity, such observational models have led to the successful
identification of a few key regulators Atf3 [51], Tgif [1], and CEBP/6 [52], but have
failed to provide a comprehensive model that explains the complexity and specificity of
the response. This is due to the limitations inherent in each approach: cis-regulatory
models are biased to regulators with known binding sites and explain little of the
26
observed expression [8], whereas trans-models are under-determined to distinguish
correlation from causation [3, 8].
A complementary strategy is to infer a perturbational model, by systematically
perturbing every regulatory input and measuring its effect on the transcriptional
output of target genes. This strategy has been successfully employed in yeast [4, 33,
43] and sea urchin [32], but not in mammals, due to the lack of efficient genetic tools
and the prohibitive cost of large-scale profiling studies. Recent technological advances
in gene perturbation and multiplex detection [8] can mitigate these limitations.
Here, we combined an observational model and perturbations to develop the first
unbiased perturbational model of a regulatory network in a mammalian cell (Fig. 2-1).
We first used transcriptional profiles and an observational model to select candidate
regulators (transcription factors, chromatin modifiers, and RNA binding proteins) for
a perturbation screen, working with the model system of primary DCs responding to
pathogens. Next we used a lentiviral shRNA library [53] to silence 125 of the candi-
dates in primary DCs. We then used an innovative and accurate multiplex detection
technology to monitor a representative signature of target gene expression following
each perturbation. The result was a perturbational model of cause-and-effect relation-
ships in the regulatory circuit controlling this transcriptional response. The unique
data generated in this work allowed us to estimate the quality of the observational
model and will assist in the development of new computational approaches to infer
regulatory models (Chapter 3). Furthermore, this systematic and unbiased approach
not only re-discovered 32 known regulators of TLR-dependent gene regulation (e.g.
NFKB, IRFs, API, STATs), but also identified another 68 regulators, which have
not been previously associated with the innate immune response and could only be
discovered by an unbiased approach.
2.3 Profiling of mRNA levels
To determine the output of pathogen-sensing regulatory networks, we measured genome-
wide expression profiles in DCs exposed to PAM3CSK4 (PAM), a synthetic mimic of
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bacterial lipopeptides; polyinosine-polycytidylic acid [poly(I:C)], a viral-like double-
stranded RNA; lipopolysaccharide (LPS), a purified component from Gram-negative
Escherichia coli; gardiquimod, a small-molecule agonist; and CpG, a synthetic single-
stranded DNA. These compounds are known agonists of TLR2, TLR3, TLR4, TLR7,
and TLR9, respectively. Poly(I:C) also activates the cytosolic viral RNA sensor MDA-
5, and LPS can also act through co-receptors such as CD14; we therefore refer to the
ligands rather than their receptors for clarity. On the basis of pilot experiments (see
materials and methods), we measured mRNA expression at nine time points - 0.5, 1,
2, 4, 6, 8, 12, 16, and 24 hours - after stimulation with these pathogen components.
These agonists and time points reflect the most dramatic gene expression changes in
DCs.
2.4 Detection of response specific genes
We focused on regulator genes whose expression change during pathogen sensing,
a reasonable assumption for many mammalian responses. We defined induced and
inhibited probesets for each condition (TLR agonist) as probesets that display at
least 1.7 fold up- or down- regulation in both duplicates of at least one time point, as
compared to the control. This set consisted of 3635 genes (Fig. 2-2). Control values
were defined as the median expression calculated over control non stimulated samples
times 0, 1, 2 and 4 hours.
Clustering the expression profiles of induced genes (Fig. 2-3A) we observed that
the transcriptional response can be classified into two major distinct 'programs' -
a 'TLR2-like' program and a 'TLR3-like' program - and a shared response (24.5%
shared by TLR2/3/4). The TLR4 response is largely the union of the TLR2 and TLR3
programs (Fig. 2-3). This is in line with the known signaling pathways controlled
by the different sensors: TLR2 depends solely on the Myd88 pathway, TLR3 and
MDA-5 depend mostly on the TRAM/TRIF and IPS-1 pathways, while TLR4 acts
through both the MYD88 and TRIF pathways [54]. It is also consistent with previous
reports of the induction of an anti-viral program by TLR3 and TLR4 [55]. The genes
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responsive in each of these programs are consistent with the type of pathogen that
elicits each response: the TLR2-like program is enriched for NFB and inflammatory
responsive genes (P< 6.1 x 10-8), whereas the TLR3 program is enriched for viral- and
interferon-responsive genes (P< 8.3 x 10-24). We thus term them the "inflammatory-
like" and "antiviral-like" programs. The TLR7 and TLR9 responses are very similar
to the TLR4 response (more than 82% shared with TLR4) suggesting that these
pathways converge on many of the same responses as the MYD88- and TRIF- TRAM
dependent pathways. A notable exception is the small number of genes that are
specific to a single stimulus (e.g. - 250 for TLR3). For example, IFNB1, which is
crucial to elicit elimination of viral infections, is induced at high and sustained levels
in response only to TLR3 stimulation, but transiently and at substantially lower levels
in response to TLR4.
2.5 Reconstruction of an observational trans-model
of gene regulation
We next asked which regulators could account for the observed transcriptional re-
sponses. The strategy consisted in identifying potential regulators based on changes
in their own expression level (a reasonable assumption for many mammalian responses
[9, 56], including pathogen-sensing [1, 48]) that are also predictive of changes in those
of other (target) genes. To this end, we developed an extension of the Module Net-
works algorithm [3] to reconstruct an observational trans-model of gene regulation
from transcriptional profiles collected along a time course (Fig. 2-1B, top). Our
method assumes that co-regulated genes have a similar regulatory program and con-
sists of two steps: (1) divide genes into modules using the Module Networks algorithm;
(2) use a regularized linear regression model [15, 22] to learn regulatory programs with
time delays for each module that attempt to explain the expression of each module
as a function of the expression of specific regulators. This approach would capture
multiple candidate regulators with a similar role, while eliminating weak spurious con-
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tributors, and would learn the temporal lags between grouped regulators and target
genes.
Learning a network of interacting modules
We started our approach by applying the Module Networks algorithm as originally
developed [3], which assumes that the expression of the target genes in each modu-
le is governed by the same regulatory program. Module Networks uses an iterative
learning procedure using the Expectation Maximization (EM) algorithm. Each ite-
ration consists of two steps: an E-step and an M-step. In the M-step, the procedure
is given a partition of the genes into modules and learns the best regulatory program
(as a decision tree) for each module. In the E-step, given the inferred regulatory
programs, it re-assigns each gene to the module that best predicts the genes behavior
(it does not assign a regulator gene to a module in which it is also a regulatory input,
directly or indirectly). The regulatory program is chosen from a pre-defined set of
candidate regulators (typically including all known and putative regulatory factors in
a genome).
Here, we initialized Module Networks from 10 to 250 modules (in increments of 10)
and using a set of candidate regulators from a curated list of 3287 proximal regulators
of mRNA levels, including 1885 transcription factors, 1069 RNA binding proteins and
333 chromatin factors. We then chose the model whose likelihood score was 70% of
the best score, to avoid overfitting of the model to the data (at this point, a straight
line with slope approximately 1 crossed the likelihood score plot). The chosen model
consisted of 80 modules (Fig. 2-4A) of 3635 co-regulated genes.
Regulation as linear regression
The original Module Networks algorithm [3] describes the regulatory programs as
regression trees (as explained on page 15). One potential limitation of this algorithm
is that it allows only a single regulator in each split in the tree, so many correct
regulators may not be selected (see Fig. 2-5 which shows Klf4 as the top regulator).
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Once Module Networks selects one regulator that seems to split the samples well,
other regulators that are probably almost as good are not going to be added to the
regulator set: since they are correlated with the original regulator they will not add
additional information beyond the original split. To this end, a regression model
could overcome this limitation. We also reasoned that a regression tree is not an
appropriate model for time course data and that it does not exploit its full power. In
particular, Module Networks does not reflect any temporal relations in the data that
would allow for time lags. Allowing such lags is based on the observation that when
induced regulators affect a target gene's expression through their own differentially
regulated mRNA level, the induction of the target gene's mRNA expression may occur
with a time lag relative to the induction of the regulator [57]. Therefore, a regression
model could also have the potential of learning lagged relationships between groups
of regulators and target genes. In addition, a regression model seems appropriate
for our dataset since all sample are related (same cell type and system, not many
different ones where context really matters).
Thus, we decided to infer regulatory programs for the modules using Elastic Net
(EN, [22]), an L 1/L 2 -regularized linear regression procedure. EN is an algorithm
based on a regularized least square procedure with a penalty which is the sum of an
L1 penalty (like LASSO [58]) and an L 2 penalty (like Ridge Regression [59]). The
first term enforces the sparsity of the solution, doing automatic variable selection,
whereas the second term prevents arbitrary choice of only one out of several highly
correlated variables. As shown in [22], EN outperforms LASSO in terms of prediction
accuracy and tends to select strongly correlated genes into the model together when
applied to microarray data. Next, according to [22], we introduce the naive elastic
net, followed by a scaled version, the elastic net.
Elastic net regularized regression
Given a dataset with n observations (experiments) and p predictors (candidate regu-
lator genes), let y = (yi,. .. ,y be the response and X = [x1 ] ... [x,] be the model
matrix (candidate regulators' profiles), where xj = (x1,. .. ) j = 1, ... ,p are
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the predictors. With a location and scale transformation we can assume the response
is centered and the predictors are standardized,
n n n
1y = 0, Ixij=0, and x = 1, for j = 1, 2,... , p.
i=1 i=1 i=1
For any fixed non-negative A, and A2 , the naive EN criterion is defined as
P P
L(A, A2, )IY - X011 2 + A2 1 3+±A lEjI|,
j=1 j=1
and the naive EN estimator # is the minimizer of that equation, that is
3 = arg min {L (A,A, #)}.
However, Zou and Hastie [22] showed that the naive EN does not perform satis-
factorily unless it is very close to either ridge regression or the lasso. This is why it
is called naive. The naive EN estimator consists of a two-stage procedure: for each
fixed A2 it first finds the ridge regression coefficients, and then does the LASSO-type
shrinkage along the LASSO coefficient solution paths. Thus, it appears to incur a
double amount of shrinkage. A scaling transformation can improve the prediction
performance of the naive elastic net by correcting this double-shrinkage. Defining an
artificial dataset (X*, Y*) so that
X* = (1 + A2)-1/2
where I, is the p x p identity matrix, and
Y
Y* = ,
(0)
where 0 is the p x 1 0-vector, Zou and Hastie [22] showed that the naifve EN solves a
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LASSO-type problem [21] given by
(elastic net) = 1 + A20.
This kind of scaling undoes the overshrinking effect when the L1 and L2 penalties are
combined. To choose the coefficients we performed a two dimensional cross validation.
The least-angle regression (LARS) extension which implements the EN algorithm,
called the LARS-EN, outputs a sequence of variables corresponding to a given A2. A,
has a one to one correspondence with the number of iterations that the LARS-EN
algorithm was run for. Therefore selecting the active model at a given iteration for a
particular A2 would give the EN solution corresponding to particular value of (A,, A2 ).
To estimate the model parameters, we chose different values of A2 (0, 0.01, 0.1, 1,
10, 100) and the other tuning parameter was chosen using standard cross validation
procedure. The chosen A2 was the one giving the minimum cross-validation error.
The MATLAB implementation of LARS-EN available in http: //www2. imm. dtu. dk/
pubdb/views/publicationdetails .php?id=3897 was used for this work.
So, for each module generated with Module Networks, we used the LARS-EN al-
gorithm to regress the mean profile of the module's genes with a selected combination
of candidate regulators (to avoid cyclicity, we eliminated the regulator genes from the
modules in this step). Simultaneously, to maximize the utility of the temporal data,
we allowed a 'lag' of up to three time points between the expression of the regulators
and that of the target module. This reflects a possible maximum delay of two hours
between regulators and target genes (Fig. 2-6).
The EN target function optimizes only for prediction error, which is a proxy
for the goal of identifying causal variables. Since not all predictive variables are
necessarily causal, we further decided to reduced the number of selected variables
using non-parametric bootstrap [60]. We randomly sampled the module's genes with
replacement to obtain 1000 bootstrap datasets, holding off 20% of each module's genes
at a time. We applied the described EN regression to each bootstrap dataset to obtain
a set of regression coefficients /3 B, B = 1, .. . , 1000, where B indicates the index of the
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bootstrap set. Those variables with a non-zero coefficient in / 3B, defined a sparse set
of regression solutions for the bootstrap set B. In order to obtain statistically robust
variables, we computed the selection frequency, 7y,, for each variable p, defined as:
1000
6, B 6( 0) /1000,
B=1
B-
where af is the coefficient of variable p in bootstrap model B, and 6 is an indicator
function. We obtained set X* according to yp:
X* = {X, | , > 0.5, p: index of variable}.
Thus, the set X* includes variables that had non-zero coefficients for at least 50% of
the bootstrap runs. The elastic net and bootstrap procedures resulted in the choice
of 117 regulators for the 80 modules (Fig. 2-4B). These included known regulators,
from the NFkB, Stat and IRF families and novel intriguing candidates such as the
circadian regulator Timeless and the DNA methyltransferase Dnmt3a.
2.6 Selection of candidate regulators for perturba-
tion and a response signature
To minimize the bias in our choice of regulators, we used two other complemen-
tary strategies to identify additional sets of candidate regulators. First, we added 5
constitutively expressed regulators whose cis-regulatory elements are enriched in the
responsive genes. These included Irf3, Rela, Nfe212, Etsl, Creb3. Second, we com-
pared the transcriptional profiles of several known regulators to those of their targets
and found that several relations will likely be missed by the model either because of
specific 'windows' of regulation or highly non-linear relations; to maximize our ability
to understand such relations, we incorporated any other regulator that had at least
a 2-fold change in expression (22 added regulators). Overall, this resulted in 144
candidate regulators for further analysis (Fig. 2-7). The expression of the candidate
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regulators covers the full transcriptional response (27% 'TLR2-like', 46% 'TLR3-like',
30% in both responses, albeit with different kinetics).
Notably, the transcriptional profiles and timing of activation of the regulators
under TLR4 activation are conserved between DCs and the functionally similar
macrophages especially at early time points (Pearson correlation r - 0.9 at 1h,
Fig. 2-8A) and between human macrophages and mouse DC (r - 0.6 at 2h, Fig.
2-8B). This conservation supports the relevance of the regulator's transcription to
the network's function.
To facilitate large-scale perturbation and monitoring, we next determined a rep-
resentative gene signature and a time point post-stimulation that captures the com-
plexity of the different programs. We devised GeneSelector, an information-theoretic
approach, for selecting genes that are highly informative about the stimulus. In this
approach, the expression levels of all genes depend on the experimental stimulus,
and we employ conditional entropy as a measure of the remaining uncertainty about
the stimulus once the expression levels of the signature genes are known. We used
a greedy procedure to incrementally select genes that maximally reduce the entropy
given the previously selected genes. We applied this approach repeatedly to select
multiple disjoint gene sets, until we reached a set of 80 genes (the set size was limited
by the experimental detection method). We used the same approach to choose a single
time point, six hours post activation, at which the conditional entropy was minimal
and hence best distinguishes the stimuli (see materials and methods). Finally, we
chose a single treatment (LPS), since it activates both the viral and inflammatory
gene programs. By this principled selection of a 'reporter signature' and a single time
point post-stimulation we can adequately represent the complexity of the transcrip-
tional response. Notably, we added two types of internal control genes. First, we
added 10 genes whose expression level is unchanged under any TLR stimulation, but
whose (constant) basal levels vary from very low to high. Second, we added to the
reporter genes the 37 candidate regulators that had a significant mRNA level at the
6 hours time point chosen for the screen. These added genes would allow us to assess
knockdown efficacy and the sensitivity of our statistical methods. The final set thus
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included 118 'reporter' genes and 10 controls.
2.7 Perturbation experiments and network recons-
truction
To provide causal data and to rigorously test the model just described, we used
RNAi libraries to test the roles of the selected candidate regulators in controlling
gene expression. We generated a validated lentiviral shRNA library for 125 of the
144 candidate regulators (Fig. 2-9) and used it to systematically perturb each of
the regulators in DCs. To carry out our perturbational study, we selected a single
treatment, LPS, that activates the majority of both the "inflammatory-like" and
"antiviral-like" programs. After stimulation of shRNA-perturbed DCs with LPS for
6 hours, we profiled the expression of a signature of 118 marker genes (see [6] for
details on this selection) with the Nanostring nCounter system that provides a fast
and cheap multiplex assay [61].
The changes in signature gene expression resulting from infection with each shRNA
were used to construct a model that associated regulators to their targets. We ex-
pected increases in the transcript levels of reporter genes whose repressors are targeted
by knockdown, and decreases in reporters whose activators are targeted. Our false
discovery rate (FDR) model estimates the statistical significance of a change in tran-
scripts in DCs infected with a given shRNA. We controlled for gene specific noise
by comparing to changes in the expression of each gene after perturbation with the
control shRNAs (Fig. 2-10A), and for shRNA-specific noise by comparing to changes
in the expression of the control genes after a given shRNA perturbation (Fig. 2-
10B). We estimated the sensitivity of our calls from the 37 regulators, which are also
included as target reporters (Fig. 2-11).
On the basis of these results, we identified a densely overlapping network with 2322
significant regulatory connections, including 1728 activations and 594 repressions (Fig.
2-10C, red and blue, respectively, at 95% confidence). Of the 125 tested regulators,
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we confidently identified 100 with at least four targets. Among those were 24 hub
regulators that were predicted to regulate more than 25% of the 118 genes measured,
as well as 76 specific regulators each affecting the expression of 4 to 25 genes. On
average, ~ 14 (±8; SD) regulators activated a target gene, and 5 (±5.8) regulators
repressed it. Indirect effects may account for the large number of regulators we
observed for each target, and we discuss how to address those in Chapter 3.
The perturbational model captured many known regulatory relations - for exam-
ple, the NF-kB family of transcription factors (Rel, Rela, Relb, Nfkbl, Nfkb2, and
Nfkbiz) regulating their known inflammatory gene targets. Our network provided
evidence for the involvement of at least 68 additional regulators in the response to
pathogens, of which 11 were hubs not previously associated with this system.
Focusing on the network architecture, we found multiple feedforward circuits in
this response, where an upstream regulator controls a target gene both directly and
indirectly through a secondary regulator [62]. The majority (76%, 4892 of 6444) of
these feedforward circuits were found to be coherent [62], having the same direct
and indirect effect on the regulated gene. The vast majority (80%) are type I loops
[63] with all-positive regulation (e.g., Nfkbiz activates E2f5 and both activate IL-
6). Such feedforward circuits respond to persistent rather than transient stimulation,
protecting the system from responding to spurious signals, as was shown for one circuit
in LPS-stimulated macrophages [52]. Our finding suggests that coherent feedforward
loops, especially class I [62], are a general design principle in this system and may
have a physiological impact on this response.
2.8 Comparison between the observational and the
perturbation model
When we compared the results from the observational and the perturbational models,
even though there were some true positive associations in the observational model,
there were also substantial discrepancies. Fig. 2-12 illustrates the correspondence
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between the models. For example, the perturbational model indicates (confidence
value above 0.95) that Arid5a represses Cxcl5, but the pair was not captured in the
observational model (Fig. 2-13A). More importantly, we found a substantial number
of false positive relations in the observational model, mostly due to the fact that both
the correct regulator and many others have indistinguishable expression patterns
(Figs. 2-14 and 2-15). This phenomenon is observable regardless of the specific
variation of the observational model, using different time lags (none, variable lags)
and different number of treatments (all treatments or only LPS). Fig. 2-13B shows
gene pair Bbx and Hbegf which was predicted in the observational model due to the
high correlation, but where the regulatory relation was not confirmed by perturbation.
Furthermore, from the perturbational dataset, we observed that correlation is not
a good indicator of the type of activity of a gene. For example, Stat2 positively cor-
relates (r ~ 1) with Acpp and Isg2O, but the perturbational model identified Stat2
as a repressor of Acpp and as an activator of Isg2O. On the other hand, Cebpz nega-
tively correlates (r - -1) with BC006779 and Tcf4, but Cebpz activates BC006779
and represses Tcf4. These observations indicate that expression data alone do not
suffice to provide functional information about gene regulation. However, most of the
regulators predicted by the observational model were functional.
2.9 Discussion
This study opens the way for the development of a next-generation of computational
approaches to infer regulatory models from genomic data such as genome-wide expres-
sion profiles. While there are many computational approaches to derive observational
models, it has been exceedingly difficult to estimate their quality [8]. The unique data
generated in this work includes both a comprehensive set of expression profiles for
learning a model (training data), and a large scale perturbational screen for estimate
its quality (test data). The broad utility of our screen is enhanced by the largely
unbiased approach in our choice of candidates for perturbation.
The draft model predicted many of correct regulators ('key players') as well as
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validated regulatory interactions but at a cost of a relatively high false positive rate
in interactions; this was mainly due to the fact that the method is based on a linear
regression and thus many of the regressors that are selected are the ones that have a
very high absolute correlation value with the dependent variable. One potential way of
overcoming this limitation is the incorporation of cis-regulatory information [1, 50].
However, such models are,biased since they can neither detect novel transcription
factors whose binding sites are not known, nor the involvement of chromatin factors
which do not bind specific sequence elements. Indeed, only 25 of our regulators have
a known binding site matrix (at the appropriate protein family level). 12 of these
sites are enriched in our TLR responsive genes (Materials and Methods) and all are
associated with factors that are well known to be involved in this response. Sites for
some of the 12 factors (e.g. Ets1, Sp1, Klf4, Creb, Egr1, E2f, Plagll) were enriched
based on the timing of expression but not the specific pathogen. Overall, while this
analysis is consistent with our model, it did not expand the scope of regulators beyond
those previously known, and it could not discover many of the key novel regulators
in the perturbational model, since they do not have known sites.
A central goal of the study was to address the mechanistic basis for pathogen-
specific responses. Consistent with previous studies [55], we distinguished two key
programs, a PAM (TLR2)-like inflammatory response and a poly(I:C) (TLR3/MDA-
5)-like antiviral response, which are together induced by LPS, a Gram-negative bac-
terial component and a TLR4 ligand. These programs reflect both qualitative and
quantitative differences between the required functional responses, and are consis-
tent with the cross-protection between certain bacteria and virus infections [55]. The
broad effect of LPS allowed us to focus on a single stimulus and time point, but
screens with other stimuli may identify additional unique regulators.
Our study has benefited from several features of the DC system, as well as from
careful design. Most notably, the organization of the DC transcriptional response
allowed us to identify regulators with a scope much broader than the single stimulus
and time point used in our screen. Nevertheless, we except that additional functional
regulators can be identified by testing additional stimuli (e.g. poly I:C for specific
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anti-viral genes) or time points (e.g. early time points to study pulse-like responses).
Generally, this work establishes an unbiased, straightforward, and general frame-
work for network reconstruction in mammalian cells, including several strategies to
leverage shRNA for the study of gene regulation. This approach can be executed at
substantial scale and reasonable cost, and is compatible with the challenge of deci-
phering the multiple regulatory systems that operate in mammals. It can be expanded
to derive increasingly detailed models and to distinguish direct from indirect targets.
2.10 Materials and methods
Mouse dendritic cells
6-8 week old female C57BL/6J mice were obtained from the Jackson Laboratories.
Bone marrow dendritic cells (BMDCs) were collected from femora and tibiae and
plated on non-tissue culture treated plastic dishes in RPMI medium (Gibco, Carls-
bad, CA, Invitrogen, Carlsbad, CA), supplemented with 10% FBS, L-glutamine, peni-
cillin/streptomycin, MEM non-essential amino acids, HEPES, sodium pyruvate, 0-
mercaptoethanol, and GM-CSF (15 ng/mL; Peprotech, Rocky Hill, NJ). These cells
were used directly for all RNAi experiments. For all other experiments, at day 5, float-
ing CD11c+ cells were sorted on the autoMACS separator with the CD11c (N418)
MicroBeads kit (Myltenyi Biotec, Auburn, CA). CD11c+ cells where replated at a
concentration of 106 cells/ml and stimulated 16 hours post sorting.
TLR agonists experiments
All ligands were purchased from Invivogen (San Diego, CA) and used at the following
concentrations: PAM3CSK4 (250 ng/ml), polyl:C (10 ug/ml), LPS (rough, ultra-pure
E.coli K12 strain LPS, 100 ng/ml ), gardiquimod (250 ng/ml), CpG DNA (lug/ml).
We first optimized a synchronized and robust activation of CD11c+ DCs to different
ligands and found that non-charged plastics ('Petri dish') retain the DCs in a naive-
like state on the basis of both cell phenotype and selected gene markers.
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mRNA isolation
Total RNA was extracted with QIAzol reagent following the miRNeasy kit's procedure
(Qiagen, Valencia, CA), and sample quality was tested on a 2100 Bioanalyzer (Agi-
lent, Palo Alto, CA). RNA was reverse transcribed with the High Capacity cDNA
Reverse Transcription kit (Applied Biosystems, Foster City, CA). For experiments
with more than 12 samples, we harvested PolyA+ RNA in 96- or 384-well plates with
the Turbocapture mRNA kit (Qiagen) and reverse transcribed with the Sensiscript
RT kit (Qiagen).
Pilot experiments
To choose the parameters (culture conditions, ligands, and time points) for the full
experiments we conducted several pilots. We first optimized a synchronized and
robust activation of CD1ic+ DCs to different TLR ligands and found that non-
charged plastics ('Petri dish') retain the DCs in a ndive-like state based on both cell
phenotype and selected gene markers. We then used microarrays to profile mRNA
levels at a few time points to identify the time windows when: (a) DCs become
quiescent following CD11c+ positive selection; and (b) TLR ligands regulate DC gene
expression and phenotype. Next, we determined the full set of time points based on
qRT-PCR measurements of a small number of marker genes along a high-resolution
time course. Based on these pilot studies, we profiled mRNA expression at 9 time
points (0.5, 1, 2, 4, 6, 8, 12, 16, and 24 hours) following stimulation with Pam3CSK,
polyIC, LPS, gardiquimod, and CpG.
Array hybridizations and processing
For oligonucleotide microarray hybridization, 1.5g RNA were labeled, fragmented
and hybridized to an Affymetrix Mouse Genome 430A 2.0 Array. After scanning,
the expression value for each gene was calculated with RMA (Robust Multi-Array)
normalization [64]. The average intensity difference values were normalized across
the sample set. Probe sets that were absent in all samples according to Affymetrix
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flags were removed. All values lower than 50 were replaced by 50.
GeneSelector
To choose a set of genes that will capture as much as possible of the information on
the expression of all genes, we used an information-theoretic approach. We modeled
the expression levels X given the experimental condition C with a naive Bayes model
where the expression of gene i under condition c follows a normal distribution Xi|C =
c '- N (pic, u). In this model, the expression levels of all genes depend on the
experimental condition C, and we selected genes that are highly informative about
C.
Formally, for a set of genes Y we used the conditional entropy
H (C|Y) = -( (C = c) Ep(Y = y|C = c) log p(C = c|Y = y)
C y
as a measure of the remaining uncertainty in C once the expression levels Y are
known. We then used this measure and a greedy procedure to select multiple disjoint
gene sets Y1, . . . , Yk, such that for each set Y, H (CYi) < r/ (we set r = 0.5). In
the greedy procedure, we select genes one at a time, and with each selected gene
re-compute the entropy given the genes already selected in the current set. Once a
set is complete (the remaining conditional entropy is below the threshold r/), we add
all the genes to the selected set, and repeat the procedure (excluding all the selected
genes from consideration). We stop when the number of selected genes has reached a
user-defined threshold, set by the number of genes feasible for the experimental assay.
To select a time point, we used the same approach. Here, we measured entropy
under all time points for multiple randomly selected gene sets of several sizes and
plotted the average entropy for each timepoint. We chose the time point with the
minimal entropy.
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Analysis of cis-regulatory elements
Each cis-regulatory element was represented by a Position Weight Matrix (PWM).
We compiled a set of 1651 PWMs from the TRANSFAC matrix database v8.3 [65],
JASPAR Version 2008 [66] and experimentally determined PWMs [67, 68]. Given a
PWM, for each nucleotide position in the promoter of each mouse gene, we calcu-
lated an affinity score defined as the log-likelihood ratio (LOD score) for observing
the sequence given the PWM versus a given random genomic background. We then
found the best conserved motif instance over the entire promoter region. We auto-
matically computed a PWM-specific cutoff, by using the information content of each
motif, computed as the 2-IC quantile of the PWM LODs distribution. We considered
a 'hit' in the promoter if the maximal LOD score was above this cutoff. Finally, we
computed the enrichment of the motif in each of six clusters determined by the mi-
croarray experiments, using a two-sided Wilcoxon rank-sum test between the set and
the background (see Table S13 in the Science manuscript website). To ensure that
enrichment was not due to nucleotide bias within the promoter, we also shuffled the
PWM and computed enrichment for the true PWM compared to the shuffled PWMs.
A motif was considered enriched in a gene set if it passed P-value<0.01.
shRNA Perturbation experiments
We generated validated shRNAs that knockdown each of the regulators by at least
75%. For each regulator, we tested five shRNAs [53] by introducing each shRNA
into in vitro cultured mouse bone marrow cells using a lentivirus expression system
followed by puromycin selection. We tested the effect of each shRNA on the target
transcript using qPCR and found an shRNA with a knockdown efficiency greater
than 75% for 125 of our 144 regulators. Our lentivirus-infected bone marrow cell
population was composed of 90% DCs as determined by FACS using the CD11c
marker. Smaller populations of uncharacterized cells largely retain the expression
profiles of DCs for most genes, including the regulators. Lentivirus infection four
days prior to TLR4 stimulation does not significantly activate the DC population,
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as reflected by the very low expression levels of major cytokines and co-stimulatory
molecules, comparable to that of uninfected cells. Furthermore, the infected cells
retain the ability to robustly respond to a pathogenic stimulus. Finally, knockdown
of the individual regulators does not cause a significant change in differentiation or
basal activation of the DC population prior to LPS treatment, as reflected by staining
of each knockdown with CD11c, a positive marker for mature DC, and with CD86 a
marker for 'activated' DC.
Reproducibility and reliability of perturbation experiments
The results of the perturbation experiments are highly reproducible and reliable as
indicated by several controls of sample variability. First, biological duplicates follow-
ing re-infection with eight of the shRNAs on different cells from the same mouse were
highly correlated (r > 0.995 in all cases; a technical duplicate has r > 0.99989). Se-
cond, biological duplicates following re-infection with 18 of the shRNAs of a new batch
of bone marrow cells from a different mouse were also highly correlated (r > 0.9).
Third, infection with a lentiviral vector harboring a second shRNA construct for 18
of the tested regulators led to correlated effects (r > 0.8). Notably, these additional
constructs resulted in a lesser, though still robust, knock down efficiency greater than
60%. Fourth, the mRNA levels measured by the nCounter assay were consistent with
qPCR validation for four target genes (IL-12, PTGS2, IL6, CXCL1O) tested under
20 different shRNAs in an independent experiment, demonstrating the robustness of
these results. Finally, the mRNA levels measured by nCounter following infection
with five shRNAs targeting regulators and two control non-targeting shRNAs were
highly (r > 0.88 in all cases) correlated to those measured on Affymetrix following
independent infections with the same constructs.
mRNA measurements with nCounter
Details on the nCounter system are presented in full in [61]. CodeSets were constru-
cted to detect genes selected by the GeneSelector algorithm and additional controls as
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described. 5*104 bone marrow cells were lysed in RLT buffer (Qiagen) supplemented
with #-mercaptoethanol. 10% of the lysate was hybridized for 16 hours with the
codeset and loaded into the nCounter prep station followed by quantification using
the nCounter Digital Analyzer.
Normalization of nCounter data
We normalized the nCounter data in three steps. In the first step, we controlled for
small variations in the efficiency of the automated sample processing. To this end,
we followed the manufacturers instructions, and normalized measurements from all
samples analyzed on a given run to the levels of a chosen sample (in all cases we
used the first sample in the set). This was done using the positive spiked-in controls
provided by the nCounter instrument.
In the next step, we relied on ten control genes (1k, Ndufa7, Tomm7, Tbca, Ndufs5,
Ywhaz, Meal, Rbm6, Shfml, and Gapdh) which were included as reporters and were
identified from the microarray experiment as unperturbed upon stimulation by any
of the pathogen components. We found that two of these genes (Gapdh and Rbm6)
showed too much variation and removed them from all subsequent analysis. We used
the remaining eight genes for a second round of normalization. For every sample, we
computed the weighted average mi of the mRNA counts of the seven transcripts and
normalized the samples values by multiplying by the constant m1 /mi. Finally, we
obtained a normalized expression quantity that takes into account the intrinsic noise
in our system. We used the 32 samples treated with control shRNAs (that do not
target any gene in the mouse genome) to define a z-statistic z for each observation
oij of transcript i in each shRNA experiment j: zij = o-m where my and sj are,
respectively, the mean and variance of the expression of transcript j in the control
shRNA experiments.
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Confidence estimates for differential expression in perturba-
tion experiments
We used two permutation-based approaches to estimate our confidence in an observed
z-score value for a transcript in an shRNA experiment. In the first approach, we de-
fined a per-gene confidence score for each measurement, by using the variation in that
gene's expression in the control shRNA experiments. We computed the confidence
scores for each measurement (one gene in one experiment) at a time, by swapping
the measured value of that gene with each of its measurements in the control experi-
ments in turn, and re-calculating a new z-score. We then assessed the significance of
the real z-score, given the distribution of the permuted scores as a null distribution.
More formally, for each of the observed counts oij of the reporter gene i in sample
j we generated r permuted values (where r is the number of control shRNA expe-
riments) as follows. Let ci,... , ci, be the r transcript counts for gene i in each of
the r control experiments. The k permuted z-score is obtained by swapping oij with
Cik and computing a z-score as zy = cik ml, where mik = i**+...+Cik1+Oij+Cik+1+..+Cir
and s . We take the
permuted scoresz as a null distribution and the FDR for a given z-score zij for gene
i in experiment j is given as FDR(z) E( #zij>z;j=,. ,n}) where n is the number
of shRNA experiments. The confidence for z is conf(z) = 1 - FDR(z).
In the second approach, we devised a per-experiment confidence score for each
measurement. We use a similar procedure to control the FDR on the z-statistic,
based on variation in the expression of control genes in each experiment. Formally,
let zij, .. . , zn be the z-scores for the jth experiment (shRNA), and assume the first I
transcripts are control transcripts whose expression does not change in response to any
pathogen component (1 = 8, see above). We defined zij= zs'"fj where now frt and
§j are, respectively, the mean and variance of the z-scores of the control transcripts
1,. ... , 1 in the jth shRNA experiment. We perform I permutations as described above,
by swapping each observed z-scores with a control transcript score and computing z,
then computing an FDR as above.
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False Discovery Based (FDR) model
We used the signature measurement across 125 genetic perturbations to construct a
regulatory model, associating regulators to their targets. We expect an increase in
the transcript levels of a reporter gene whose repressor is targeted by knockdown,
and a decrease in a reporter whose activator is targeted. We devised a statistical
procedure to estimate, at a desired FDR, which transcripts are significantly decreased
or increased in DCs infected with a given shRNA, as compared to their expected
level in the absence of the shRNA perturbation. Our procedure controls for two
potential sources of noise. First, we assess gene-specific noise based on changes in
the expression of each reporter gene following infection with 32 control shRNAs (Fig.
2-10A). Second, we assess shRNA-specific noise based on changes in expression of
8 control genes following a given shRNA perturbation (Fig. 2-10B). (These control
genes do not change following any TLR stimulation in wild type DCs). Together,
these methods allow us to devise two confidence measures to estimate the significance
of change in each reporter gene under each shRNA perturbation.
We estimated the sensitivity of our calls based on our ability to accurately iden-
tify the knockdown of the 37 regulators that are also included as target reporters
and should be knocked down by specific shRNAs (two additional regulators, Fos
and Klfl0, are included as targets but are themselves down regulated in the na-
tive response and hence cannot be scored). At 95% confidence, the gene-specific
FDR accurately scored the knockdown target as significantly repressed for each of
these 37 genes. The shRNA-specific FDR accurately scored 80% of the 37 regula-
tors/targets as significantly repressed. This suggests that our second FDR is likely
an over-conservative estimate of the confidence.
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2.11 Figures
A Measure states
Genomewide mRNA expression
Stimulation
B Gene selection
Select regulators
Select output genes
Selection of minimal set of
regulated genes
C Network perturbation
RNAi perturbation
J-l K
Stimulation
Measure mRNA levels using a
multiplex measurement method
D Construct network
Develop network model
based on data
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Figure 2-1: A systematic strategy for network reconstruction. The strategy consists
of four steps (left to right). (A) State measurement. We use genome wide expression
profiles under different stimuli (S1-S5), at different time points (tick marks). Rows genes,
columns experiments, red induced, blue repressed, white unchanged. (B) Gene selection.
We identify candidate regulators that are transcriptionally regulated and predictive of the
expression of gene modules (top). We select a signature of target genes that maximally
represents the full expression profile (bottom). (C) Network perturbation. We generate a
functionally validated shRNA library for all potential regulators and use it to knockdown
each regulator (top). Following stimulation of genetically perturbed cells (red arrow), we
measure the expression of the signature genes using the nCounter multiplex mRNA detection
system (bottom) (D) Network reconstruction. We combine genome-wide expression profiles
and perturbed multiplex measurements to reconstruct a regulatory network associating
regulators with individual targets and overall responses.
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Figure 2-2: Expression profiles of the 3635 genes whose expression was at least 1.7 fold
up- or down- regulated in both duplicates of at least one time point as compared to the
control, in CD11c+ DCs stimulated with the indicated pathogen component across a time
course of 0, 0.5, 1, 2, 4, 6, 8, 12, 16, or 24 hours (tick marks). Replicates were collapsed
and genes hierarchically clustered (rows, genes; columns, experiments; red, induced from
baseline; blue, repressed from baseline; white, unchanged from baseline).
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Figure 2-3: Gene expression response to pathogen components. (A) mRNA profiles of the
1800 genes whose expression was induced by a factor of at least 1.7 from baseline level in both
duplicates of at least one time point in CD11c+ DCs stimulated with the indicated pathogen
component across a time course of 0, 0.5, 1, 2, 4, 6, 8, 12, 16, or 24 hours (tick marks;
pIC, poly(I:C); GRD, gardiquimod). Replicates were collapsed and genes hierarchically
clustered (rows, genes; columns, experiments; red, induced from baseline; blue, repressed
from baseline; white, unchanged from baseline). (B) Model illustrating the differential gene
regulatory networks controlling the antiviral ["poly(I:C)-like"] and inflammatory ("PAM-
like") programs.
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Figure 2-5: Example module. Rows are genes,
represents the regulatory program for the module.
columns are experiments, and the tree
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BFigure 2-4: A module networks-LARSEN model of candidate regulators and target mo-
dules. (A) Mean expression of each of 80 modules (rows) across the five time courses. Red
- induced; blue - repressed; white - unchanged; all values are relative to the t=0 baseline.
(B) The regulators (columns, hierarchically clustered) associated with each of the modules.
Black/brown - positive/negative coefficients from the regularized regression (the stronger
the color intensity the higher the regression coefficient). Rows are hierarchically clustered
according to the mean expression data in (A).
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Figure 2-6: Three modules and the regulatory programs learned with the LARS-EN
approach across the five time courses of 0, 0.5, 1, 2, 4, 6, 8, 12, 16, and 24 hours (tick marks
show both replicates for each time point) for the five stimulated pathogens. Rows are genes,
columns are experiments, the regulatory programs are above the grey row for each module.
(A) Target module with no time delay. (B) Target module with 0.5h time delay. (C) Target
module with 2h (maximum) delay.
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Figure 2-7: Gene expression profiles of selected regulators. CD11c+ dendritic cells were
stimulated with the indicated pathogen component across a time course of 0, 0.5, 1, 2, 4, 6,
8, 12, 16, 24 hours (tick marks), followed by measurement of whole genome mRNA profiles.
Shown are the expression profiles for the 144 TFs, RNA binding proteins and chromatin
modifiers selected for perturbation. Replicates are collapsed and genes are hierarchically
clustered.
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Figure 2-8: Correlation between mouse DC profiles to mouse macrophages and human
DCs. A) Pearson correlation coefficients between the expression profiles in this study
(columns) and in LPS-stimulated mouse macrophages (15) (rows), when the profiles are
restricted only to the 144 regulators as in Fig. 2-7. B) Correlation between the expression
profiles of human macrophages and mouse DCs both stimulated by LPS, on the basis of
only 89 regulator genes. The 89 regulators are all those out of the 144 candidates (as in
Fig. 2-7) that could be mapped between the two organisms and arrays.
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Figure 2-9: Validation of shiRNA knockdown efficiency. Five lentiviruses expressing in-
dependent shRNAs targeting each of 144 induced regulators were generated (top). Bone
marrow cells were infected with control or regulator shRNA viruses and stimulated for 2
or 6 hours with LPS (middle). PolyA+ RNA was prepared and reverse transcribed with
random nonamers followed by quantitative real-time PCR with primers specific to each
regulator gene. Relative knockdown efficiency for each regulator was calculated relative to
its level in a set of experiments with control shRNAs ('Ctl') (bottom). 125 of 144 candidate
regulators had an shRNA which caused greater than 75% knockdown.
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Figure 2-10: Gene regulatory programs controlling the response to pathogen components. (A
and B) A strategy to minimize the false discovery rate (FDR) calls of significant changes in an
output target gene resulting from knockdown of a regulator gene. (A) The first FDR procedure
(top) compares the expression of the gene after a perturbation with a regulator shRNA (right) to
its expression upon perturbation with 32 nontargeting shRNAs (left). The dashed lines identify the
gene-specific FDR-based thresholds for induction (blue line) and repression (red line). A discrete
vector of significant calls (bottom) is derived from the raw data (blue, regulator represses the target
gene; red, regulator induces the target gene). (B) A second FDR procedure (top) compares the
expression of the target gene to that of eight control (target) genes upon perturbation with the
same shRNA. In the example shown, the genes induction (left) was significant relative to the vari-
ation in expression among the control target genes, resulting in a high score (bottom, dark blue),
but its repression did not significantly differ from the controls, resulting in a lower score (bottom,
weaker red). (C) A heat map showing all the significant relations between the perturbed regulators
(columns) and the measured targets (rows), colored as in (B). Darker colors - high-confidence calls
passing both a gene-noise model (FDR#1) and an shRNA-noise model (FDR#2) at 95% confidence.
Light colors - calls passing only the gene-noise model at 95% confidence.
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Figure 2-11: FDR values for 39 regulators that were also included in the 118 signature set.
Shown are the FDR values for induction (red) and repression (blue) for each of the 39 regulators
that were also measured as target genes (rows), in the 39 experiments that target these regulators
with shRNA (columns). The rows and columns are sorted in the same order. (A) FDR#1 (gene-
specific) correctly scores all knockdowns, except for two genes (Fos, KlflO) that are repressed by
the response in wild-type cells and hence cannot be assessed. (B) FDR#1 followed by FDR#2
(shRNA-specific) correctly scored 80% of knockdowns (i.e., 20% of shRNAs targets were not called
as significant due to effects on expression of control target genes).
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Figure 2-13: (A) Expression profiles of two genes whose interaction was identified in the
perturbational model, with confidence value above 0.95, but that was not predicted in the
observational model. (B) Expression profiles of two genes whose interaction was predicted
by the observational model but not found in the perturbational model.
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Figure 2-12: True-false positive and negative associations in the observational model.
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Figure 2-14: Correlation between expression of regulator and that of its target and non-
target genes. Shown are distributions of Pearson correlation coefficients (dark red) and the
best correlation coefficient when allowing a lag of up to 4 time points (3) (blue - no lag, light
blue - 0.5 h lag, green - 1h lag, orange - 2 hour lag). The coefficients are calculated in the
following way. A. between all confident (FDR#1 and FDR#2 > 0.95) regulator-target pairs,
with expression data from all treatments; B. between all confident (FDR#1 and FDR#2
> 0.95) regulator-target pairs, with expression data from the LPS time course only; C.
between all non-regulator-target pairs (FDR#1 and FDR#2 < 0.2), with expression data
from all treatments; D. between all non- regulator-target pairs (FDR#1 and FDR#2 <
0.2), with expression data from the LPS time course only. The distributions for correct
regulator-target pairs and false pairs are highly similar, indicating the high number of false
positives in trans-models.
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Figure 2-15: Regularized regression coefficients between expression of regulator and that
of its target and non-target genes. Shown are distributions of the coefficients from the
L2-regularized regressions chosen when allowing a lag of up to 4 time points (blue - no lag,
light blue - 0.5 h lag, yellow - 1h lag, red - 2 hour lag). The coefficients are calculated in the
following way. A. between all confident (FDR#1 and FDR#2> 0.95) regulator-target pairs,
with expression data from all treatments; B. between all confident (FDR#1 and FDR#2
> 0.95) regulator-target pairs, with expression data from the LPS time course only; C.
between all non-regulator-target pairs (FDR#1 and FDR#2 < 0.2), with expression data
from all treatments; D. between all non-regulator-target pairs (FDR#1 and FDR#2 <
0.2), with expression data from the LPS time course only. The distributions for correct
regulator-target pairs and false pairs are highly similar, indicating the high number of false
positives in trans-models.
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Chapter 3
Systematic identification of
topologically essential interactions
in regulatory networks
3.1 Abstract
Screens monitoring the effects of deletion, knock-down or overexpression of regulatory
genes on the expression of their target genes are critical for deciphering the organi-
zation of complex regulatory networks. However, since perturbation assays cannot
distinguish direct from indirect effects, the derived networks are significantly more
complex than the true underlying one. Previous approaches to identify a minimal
network topology consistent with the results of a perturbation screen only presented
approximate methods with major limitations and are often applicable only to simple
network topologies.
We present Exigo, an approach to systematically find a family of core networks
for an input network of any topology with an arbitrary number of activating and
inhibiting interactions. Using a novel matrix representation of the network topology
we reduce the problem of identifying the core underlying networks to counting self-
avoiding random walks on the original network. This systematic approach allows
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us to globally analyze the network's topology to determine the functional effect of
modifications such as edge removal.
Exigo outperforms previous approaches on simulated data, successfully uncovers
the core network structure when applied to real networks derived from perturbation
studies in mammals, and improves the performance of network inference methods,
thus providing a valuable tool for accurate global analysis of gene regulatory networks.
Exigo is available for download at http://www.broadinstitute.org/regev/exigo.
3.2 Background
Systematic perturbation of genes by genetic manipulation or RNAi is a major tool
in functional genomics [69, 70]. When coupled to a readout measuring mRNA levels,
perturbation screens allow us to decipher the functional relationship between a regu-
lator and its targets, thus providing new insights in understanding the complexity of
gene regulatory circuits [6, 33, 69, 71].
However, genetic perturbations alone cannot distinguish between direct molecular
effects of a transcription factor on its targets and indirect effects through additional
layers in the circuit. These indirect effects result in 'extra' edges in the network, ren-
dering it more complex than the 'real' biological ones. Pruning such indirect edges
is important for the interpretation of biological screens as well as for the develop-
ment of effective network inference networks. In particular, the DREAM4 challenge
[72] indicates that the best-performing inference methods were those that leveraged
information from perturbation screens through various topology analysis approaches
[40, 73].
Previous studies [34, 35, 74] have formulated the problem of the identification of
indirect interactions as finding the sparsest (most parsimonious) network consistent
with the experimental observation, where the experimental observation is represented
by a signed interaction graph reflecting all the experimentally-identified interactions
(many likely indirect). In principle, multiple networks may be consistent with a given
experimental interaction graph (Fig. 3-1). We term all of these as experimentally
66
equivalent networks, to indicate that one cannot distinguish between them based on
a single-gene perturbation experiment alone.
The identification of all the experimentally equivalent networks consistent with
the result of a perturbation experiment is a significant theoretical and computational
problem. Published studies [36, 38, 40, 74-76] presented only a few methods for find-
ing the sparsest network, each suffering from inherent limitations. Pioneering work
[34] showed how a graph-theoretical method of transitive reduction could be used to
find the most parsimonious genetic network for acyclic networks. In this transitive
reduction approach, edges whose effect can be recapitulated by alternative interac-
tion paths are considered unnecessary and are iteratively removed. This approach has
been extended to handle some higher-order topological effects [35] or to use associated
experimental data, such as confidence measures [38, 40]. However, these procedures
are limited due to either the nature of approximations made or their extreme compu-
tational intensiveness. On the one hand, most approaches fail to accurately account
for global effects caused by edge removal, when a particular edge contributes to an
indirect interaction between a distant pair of nodes. In an alternative approach, the
TRANSWESD [40] algorithm accounts for this limitation, by the enumeration of all
possible random walks on the network. While this guarantees that for every experi-
mentally observed interaction there is a path in the core network that recapitulates its
effect, it is computationally very intensive [40] and, thus, cannot scale for realistically
large biological networks. Finally, all transitive reduction methods ignore the non-
uniqueness of the most parsimonious graph: sequential edge removal only allows the
identification of a single graph. Thus, to the best of our knowledge there is currently
no systematic procedure to determine if two or more networks have the same outcome
in a genetic perturbation experiment, and hence no formal way to assign networks to
equivalence classes with respect to a set of experimental observations ('observability
classes').
Here, we present Exigo, a comprehensive approach to find multiple core networks
consistent with experimental observations. Exigo uses an adjacency matrix represen-
tation of interacting networks and introduces novel matrix transformations to uncover
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the relation between different networks that can produce the same experimental obser-
vations. Rather than enumerating all possible paths on the network, Exigo leverages
the fact that a signed accessibility graph results from a cumulative effect of all possi-
ble self-avoiding walks on the network. It then computes these efficiently to generate
a reference matrix that encodes a representation of all possible connections for the
entire class of experimentally equivalent networks. Using the reference matrix, Exigo
directly checks if removal of any one or more matrix entries (i.e., one or more network
edges) would change the observability class of the modified network.
We apply Exigo to analyze the network structure of both simulated and biologi-
cally derived regulatory networks, which contain activations, inhibitions and cycles,
and demonstrate that the method is applicable to networks of any topological com-
plexity. Furthermore, we incorporate our topological analysis module into a state-of-
the-art network inference procedure [73] and show that performance is substantially
improved based on DREAM4 benchmarks, surpassing the previous top performer.
3.3 Results
Exigo: a method to identify core networks consistent with
experimental observations
A given network is consistent with that defined by a perturbation experiment if and
only if every interaction that is topologically possible in one network is also possible
in the other, either directly (through one edge) or indirectly (through a multi-edge
directed path with the same composite effect of inhibition or activation). We term
all the networks that are consistent with one perturbation experiment as belonging
to one observability class.
Exigo identifies core networks consistent with an experimental observation by fol-
lowing four steps (Fig. 3-2 A). First, given an original (experimental) network, Exigo
identifies all topologically possible interactions within the network, by computing a
reference network (matrix), which encapsulates all the topologically possible interac-
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tions - direct or indirect - between the nodes of the original graph. Specifically, the
reference network has an edge between two nodes if and only if there is a path (direct
or indirect) between these nodes in the original network. The reference network thus
extends the notion of an accessibility graph as defined originally in [34]: it is defined
for networks with both activating and inhibiting interactions and with arbitrary com-
plex topological elements, such as feedback loops. In particular, networks belong to
the same observability class only if they generate (converge to) the same reference
matrix. Second, Exigo attempts to remove single entries in the experimental net-
work, one at a time, to identify all the edges that can be individually removed, while
still being able to generate (converge to) the same reference matrix. However, this
does not mean that these individual non-essential edges may all be removed together.
Specifically, some subsets of edges are degenerate, they can each be individually re-
moved but they cannot be simultaneously removed (e.g., edges AC and BC in the
network (I) in Fig. 3-2 A). Third, Exigo identifies a subset of individual non-essential
edges contained within such degeneracies. Finally, Exigo simultaneously removes all
the individual non-essential edges that are not contained within the degeneracies in
order to obtain a reduced network that belongs to the same observability class. In
addition, the remaining degeneracies are marked and reported.
Notably, for sufficiently complex networks, some of the edges that were considered
as essential in the initial network become non-essential in the reduced network, due
to the simplification of the global network structure. Thus, Exigo iteratively repeats
steps 2-4 (i.e., removing the edges and testing convergence of the modified network to
the original reference matrix derived from the experimental data, see Materials and
methods) until all the individually non-essential edges that are not contained within
degeneracies are removed and the reduced network cannot be further simplified.
Computation of the reference matrix
To construct the reference matrix (Fig. 3-2 B), we first represent the experimental
network by its signed adjacency matrix, M, with rows corresponding to regulator
nodes and columns to target nodes. Each entry MM is either -1 (inhibition), +1
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(activation), or 0 (no interaction) depending on the functional interaction between
regulator i and target node j. Due to the nature of perturbation experiments, where
the regulator is removed genetically or by shRNAs, diagonal entries are not well
defined, but as we show below should be set to zero.
Next, we use matrix multiplication to identify all paths ('walks') from a given
regulator node i to a target node j in the experimental matrix. We note that the
nth power M" of matrix M has all such paths of length n, with the sign of the entry
corresponding to the effect of i on j through such paths. For example (Fig. 3-2 B),
after squaring matrix M 1 , entry M 2 ,4 ) will be -2, consistent with two paths of length
2 in the experimental network, namely BCD and BAD, each mediating an inhibiting
interaction.
When considering biological networks, one excludes as unrealistic all paths that
pass the same node more than once when connecting node i to node j, such that
only self-avoiding walks are considered [77]. To achieve this, we replace the diagonal
elements by zeros after each round of multiplication (Fig. 3-2 B). Since this violates
the commutative property of multiplication, in order to proceed to the next order we
always multiply the original matrix from the right as,
M x O ""O gonal M2 ; Ml2 x M1 Os on digonal M 3; etc. (3.1)
where M 1 is the matrix representing the original network and M" describes all self-
avoiding paths of length n within M 1 . Naturally, nm,, should not exceed the number
of nodes in M 1 (the largest self-avoiding random walk would involve all nodes).
"Weighing and thresholding" procedure
Notably, until this point, the procedure outlined above is virtually identical to those
previously described for self-avoiding walks [783. Such procedures then follow with
direct enumeration of self-avoiding walks. This is required to distinguish between self-
avoiding walks and loops that end at previously visited nodes, but is computationally
prohibitive, exponentially in the rank of the matrix.
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We address this challenge by a "weighing and thresholding" procedure, where each
matrix Mi is weighted by successively smaller weights. This procedure eliminates the
contribution from loops to the reference matrix. We rely on the fact that for any
interaction between two nodes, the shortest path that connects them is a self-avoiding
path with no loops and, thus, it will determine the sign of the interaction, as long as
shorter paths are weighted higher than longer paths. Thus, once the sign function is
applied to a weighted sum of matrices M, only contributions from self-avoiding walks
will remain.
The weighing factors wi, which allow us to exclude loops from consideration, play
a fundamentally different role than that of the various weighted measures previously
introduced in studies of network topologies. For example, communicability between-
ness [79] reflects the balance between information propagation along the short and
long paths and serves as an effective parameter to tune the importance of the inter-
action length (also, this concept is applied to nodes). In Exigo the weights wi do not
depend on specific biological knowledge on the strength or confidence of individual
interactions.
It is possible for two or more different indirect paths from one node to another
to deliver contradictory signals (e.g. inhibitory vs. activating arms of an incoher-
ent feed forward loop). Since their combined effect cannot be unequivocally iden-
tified on topological grounds alone, we assume that in cases of paths of different
length, the input through the shortest path determines the overall effect on the node.
To reflect this, we choose weights wi as exponentially decreasing positive numbers,
W1 =1 >> w 2 >> W3 >> ... >> 0, thus ensuring that the shortest path always
overpowers any combined contradictory effect of longer paths and hence determines
the sign of the entry in Mum. Similarly, for conflicting paths of the same length we
assume that they cancel each other, since topologically both paths are of the same
"strength". In general, competing paths of any length can be compared through
the use of confidence measures for individual interactions and appropriate rules for
calculating the confidence of multistep path.
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Thus, the reference matrix is obtained through:
nmax
M = flmax wi I (3.2)
i=1
where higher weights are used for shorter paths and nmax is found iteratively by fol-
lowing the convergence of the reference matrix. Upon convergence, Exigo discretizes
all the values in MuNm, setting all positive values to +1, all negative values to -1 and
keeping 0 values.
Complexity
The reference matrix is computed in polynomial time (in the number of nodes, or
matrix rank), since the longest self-avoiding walk cannot be longer than number of
nodes n in the network. The procedure's running time is O(2n') (see Methods for
details).
The reference matrix, Mreference, is akin to the path matrix of the original matrix,
M 1, except that it is signed to represent negative or positive interactions. To compute
the path matrix of a graph is equivalent to creating a data structure that contains
reachability information about a graph. This similarity is explained as follows:
Let G = G(V, E) be a directed graph with n vertices vV2, ... , v,. The path
matrix or reachibility matrix of G is the n-square matrix P = (pij) defined as follows:
1, if there is a path from vi to v
Pij =
0, otherwise
Suppose now that there is a path from vertex vi to vertex vj in a graph G with n
vertices. Then there must be a simple path from vi to v when vi -$ vj, with length
n - 1 or less, or there must be a cycle from vi to v when vi = vj, with length n or
less. This means that there is a nonzero ij entry in the matrix
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where A is the adjacency matrix of G. To generate P, we replace the nonzero entries
in B, with 1.
In Exigo, we added a weighting scheme to this procedure as explained above to
efficiently compute collective, global effects of all self-avoiding walks in the network,
while bypassing the need for exact enumeration of self-avoiding walks of every length
(the exponential complexity of the enumeration problem would be computationally
prohibitive [80]). Exigo's reference matrix computation is a major improvement over
the exponential cost of exhaustive enumeration. To confirm the practical accuracy of
our procedure, we compared our procedure for reference matrix construction to the ex-
act procedure based on "direct enumeration" of self-avoiding walks on a compendium
of 10,000 random networks. Specifically, we have constructed random networks of
various sizes (n < 100) by assigning randomly +1,-i or 0 to every entry of adjacency
matrix. Then, for every randomly constructed network we constructed all possible
self-avoiding directed paths by enumerating all the possibilities. Based on the ob-
tained compendium of these walk, we have constructed a reference matrix for every
network, assigning +1 to indirect interactions when two nodes were connected acti-
vating shortest self-avoiding path; -1, when shortest self-avoiding path was repressing
and 0 when there were no indirect paths connecting two nodes. We then compared
the reference matrix constructed in such way to the one constructed through Exigo's
reference matrix procedure. These two reference matrices were identical for all 10, 000
randomly constructed networks.
In 1960, S. Warshall described an algorithm which is more efficient than calculating
the powers of the adjacency matrix [81]. It has a worst case complexity of O(n 3 ) where
n is the number of vertices of the graph. Warshall's algorithm consists in defining
n-square Boolean matrices Po, P1,... , P, as follows. Let Pk[i, j] denote the ij entry
of the matrix Pk, so that
1, if there is a simple path from vi to v which does not use any other
Pk[i,j] vertices except possibly v1 , v2 ,... , Vk
0, otherwise
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That is,
Po[i, j] = 1 if there is an edge from vi to v
P1 [i, j] = 1 if there is a simple path from vi to v which does not use any other
vertices except possibly vi
P2 [i,j] = 1 if there is a simple path from vi to v which does not use any other
vertices except possibly vi and v2
And so on.
The first matrix is the adjacency matrix of G (i.e., P = A), and since G has only n
vertices, the last matrix is the path matrix of G (i.e., P, = P). Warshall noted that
Pk[i, j] = 1 can occur only if one of the following cases occurs:
" There is a simple path from vi to v which does not use any other vertices except
possibly v1, v2 ,... , vk_1; hence
Pki[ij] = 1
" There is a simple path from vi to Vk and a simple path from Vk to V where each
simple path does not use any other vertices except possibly v 1 , v 2 ,. . . ,v1;
hence
Pk_1[i,k]=1 and Pk-_[kj]=1
Thus, the elements of Pk can be obtained by
Pk[i,j] = Pkl[i, j] V (Pk-_[i, k] A Pk_1[k, j])
where the logical operations V (AND) and A (OR) are explained in Tables 3.1 and
3.2 below. In other words, each entry in the matrix Pk can be obtained by looking at
only three entries in the matrix Pk-1.
While Warshall's algorithm is appealing, if we apply it to a graph that has both
positive (+1) and negative (-1) entries, it fails in taking into account the existence of
conflicting paths of the same length. In Exigo, we assume that they cancel each other,
since topologically both paths would have the same "strength". This cumulative effect
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A 0 1 V 0 1
0 0 0 0 0 1
1 0 1 1 1 1
Table 3.1: AND Table 3.2: OR
of all paths is taken into account by Exigo but not by Warshall's algorithm (Fig. 3-3).
Identification of individually essential and non-essential inter-
actions
To identify all the edges in the original network (M 1 ) that are individually non-
essential, we construct all networks Mj that can be derived by removal of a single edge
from M 1 (there are as many Mj networks as there are edges in the original network
M 1 ). We next test whether each Mj converges to the original reference matrix: for
each MI we find the reference matrix Mreference and compare it to the reference matrix
Mreference obtained from the original network M 1 . As long as Mefeence = Mreference,
the removed edge is deemed individually non-essential, since it can be removed with-
out affecting the experimental observations. For edges identified as individually es-
sential (Meference # Mreference), we can explicitly determine which direct or indirect
interactions are lost upon removal of this edge, by comparing M/eerence to Mreference.
Importantly, identification of all the individual non-essential interactions does not
yet directly determine the core network consistent with the experimental results.
Indeed, simultaneous removal of all the individual non-essential edges may result in
a network inconsistent with the original one, due to higher-order network structures.
For example, consider the network in Fig. 3-2 A. It has three non-essential individual
edges (AC, BC and AD, network (III), Fig. 3-2A). However, two of these edges,
AC and BC, have the same effect, and are thus degenerate (networks (IV) and (V),
Fig. 3-2A): either one can be removed as long as the other is intact, but if both (or
all three edges) are removed, the resulting network is no longer consistent with the
data. When such degeneracies exist, there will be multiple core networks consistent
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with a single experimental network. Thus, we next determine which edges can be
simultaneously removed and which are part of different degeneracies.
Identification of non-essential edges embedded in degenerate
topologies
A direct and exhaustive way to identify all degenerate interactions is by systematic
removal of all possible pairs of interactions, all possible triplets, etc., comparing each
time to the reference matrix. This brute force approach is akin to a power-series
expansion classically employed in statistical physics. Unfortunately, this approach
is computationally expensive. As a practical solution, we devised an alternative
procedure that performs well in computational time for the relatively sparse biological
regulatory networks.
Specifically, we use a stepwise, iterative procedure to identify the edges that can-
not be removed simultaneously, by sequentially removing multiple edges and test-
ing at each point the convergence to the original reference matrix (materials and
methods). Once an edge removal breaks convergence, we retain that edge in the
network. We then cyclically permute the order in which edges are removed and re-
peat the same procedure. In this way, we identify all the degeneracies that arise
due to edge redundancy within strongly connected components. In the most general
case, however, this approach does not guarantee the identification of all degenerate
entries in more complex topologies, but rather only a subset of degenerate entries
representing one subset of possible core networks. At this point, upon removal of a
fraction of non-essential edges, the remaining network consists only of essential and
non-essential-but-degenerate edges.
Breaking the degeneracies to identify a minimal core topology
consistent with experimental data
In practice, it is often important to also find a single, specific, parsimonious graph that
is most consistent with the experimental data. In fact, one can leverage experimental
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confidence measures assigned to each interaction (edge) to solve this problem. In
this case, the goal is to break the degeneracies such that only the most confident
interactions are kept among the ones involved in the degenerate subgroup.
To this end, we devised a procedure that guarantees that interactions of lower
confidence are removed first among the degenerate edges. First, we apply Exigo to
identify all the non-essential entries. Given experimental confidence measures for each
interaction, we list all topologically non-essential entries in order of increasing confi-
dence. We then attempt to sequentially remove non-essential interactions each time
testing for convergence to the original reference matrix. If convergence is maintained,
we remove the interaction, otherwise we keep it. The sequential removal ensures that
the most confident interactions within degenerate subgroups will be preferentially
kept in the core network.
Exigo finds multiple non-essential interactions in a mammalian
regulatory network
We applied Exigo to an experimentally measured regulatory network that controls
the transcriptional response of mouse primary dendritic cells (DCs) to lipopolysac-
charide (LPS) [6]. This network connects 144 regulators (each perturbed by shRNA
knockdown) to 128 targets whose expression is measured under each perturbation.
The confidence in each interaction is estimated by an FDR-based model [6].
First, we considered the sub-network composed of the 39 genes that have were both
perturbed as regulators and measured as targets. This subnetwork comprised 253
interactions: 168 activatory and 85 inhibitory. Exigo identified 44 (16%) individually
non-essential interactions in this network, 24 of which were contained in degeneracies
(Fig. 3-4A). It removed the 20 non-essential non-degenerate edges and then used the
remaining interactions' confidence measures to sequentially remove the least confident
degenerate edges, keeping only the ones that would violate the equivalence to the
experimental network. Overall, it removed 37 of the 44 interactions individually
non-essential interactions without breaking the convergence to the original reference
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matrix (Fig. 3-5). Thus, the resulting minimal core network that is most consistent
with experimental observations contains 216 edges between 39 nodes.
To characterize the effect of edge removal on the network's topology, we studied the
local connectivity patterns in the experimental (original) and pruned (core) networks.
We analyzed the number of feed-forward loops of each of 8 possible canonical classes
[63] in each of the two networks (Fig. 3-4 B, 3-6). Despite the fact that only a
small fraction of edges (- 10%) are non-essential, the number of feed-forward loops
decreased by over 30% (from 464 to 310). Importantly, the relative proportions of
different classes of loops remained the same (Figs. 3-4 B, 3-6).
Furthermore, we tested how the choice of non-essential interations identified by
Exigo was related to TF-DNA binding data. To this end, we compared Exigo's
result to a High-Throughput Chromatin ImmunoPrecipitation (HT-ChIP) dataset
(unpublished data) that builds genome-wide binding maps for 29 transcriptions fac-
tors following stimulation of primary innate imune DCs stimulated with the pathogen
component LPS. We focused in 8 of these transcription factors (Egr2, Fos, Irf1, Irf2,
Nfkb2, Rel, Stat1, Stat2) for the comparison, since they are the ones also present
in the perturbation network analysed with Exigo. We found out that 8 out of 9
non-essential interactions have no binding and that 5 out of 7 non-essential degener-
ate interactions have no binding. However, we also identified 49 out of 73 essential
interactions with no binding; this may be due to the fact that intermediate genes
are responsible for the causal effect observed in these 49 essential interactions in the
perturbation screen.
A relatively small number of redundant edges between regulators might lead to
large redundancies in the effects that the regulators exert on other (non-regulator)
target genes. To study this, we next considered the complete experimental network
(144 perturbed regulators, 128 targets) [6]. The adjacency matrix has size 233 x 233
(144 regulators + 128 targets - 39 both regulator and target = 233) and contains
1,774 non-zero entries. Exigo identified 725 individual non-essential interactions, 134
of which were contained in degeneracies. Using the confidence values associated with
each interaction [6], Exigo further parsed the degenerate entries to retain only 1,112
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topologically essential edges, thus removing 38% of the interactions found in the initial
screen as topologically non-essential and hence possibly indirect.
Exigo can be used for the analysis of networks of any complex
topology
Experimentally-determined networks, even small ones, typically include multiple, of-
ten entangled, feedback loops, but all previously published methods are limited in
their ability to handle such structures. To illustrate this, we consider a small syn-
thetic network of 10 nodes and 19 interactions (Fig. 3-7). Exigo uncovered the
structure of the minimal solution, identifying five non-essential edges, two of which
are in a degeneracy. Breaking this degeneracy leads to 2 possible minimal networks,
each with 15 edges. In contrast, despite the small size of the network, none of the
available methods - SOS Pruning [38], NET-SYNTHESIS [39] and TRANSWESD
[40] correctly identified any of these topologies.
In fact, some of the edges determined as non-essential and removed by some of
these alternative approaches cannot be reconstructed (as an indirect path) from the
resulting core network, indicating a significant failure. Notably, only TRANSWESD
(relaying on exhaustive enumeration) ensures that any removed interaction can still be
recapitulated by an indirect path. However, not only TRANSWESD is computation-
ally highly intensive (e.g., more than to 5 hours on an Intel Core 2 Quad CPU Q6700;
2.67 GHz for a 100-node network), it does not account for the length of these indi-
rect paths. This leads to the counterintuitive situation where the shortest (indirect)
path between two nodes A and B in the core network has an effect opposite to that
of the removed direct edge between these nodes (e.g., upon removing an activating
edge A -+ B, the shortest indirect path between A and B is inhibitory). Conversely,
in Exigo all of the experimentally observed interactions are always represented by
shortest paths of the same sign.
To further evaluate the performance of our approach, we analyzed a compendium
of biologically-motivated synthetic networks. First, we generated 60 'ground truth'
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networks by sampling in each case a 100-node sub-network from the S. cerevisiae
real regulatory network, using GeneNetWeaver [82] with settings corresponding to
the DREAM4 challenge (Materials and methods). The sampled genetic networks
had 285 edges on average (±8). Next, we used GeneNetWeaver [82] to generate a
corresponding experimental perturbation network for each 'ground truth network' by
simulating a set of deletion experiments on each of the nodes in each network. On
average, the perturbation networks contained 275 edges (±35), only 125 (±14) of
them true positives. This fraction is consistent with previously published results [40].
On average, Exigo identified 100 (±20 STDV) non-essential edges with 30 (±10
STDV) of them contained in different degeneracies. These non-essential edges con-
sist primarily of false positive edges (Table 3.3 and Fig. 3-8). Thus, the reduced
(pruned) networks contained on average only 67% of the edges in the perturbation
network (183 ± 23 edges), while still maintaining the vast majority (91%, 114 ± 11
edges) of the 125 true positive edges (see Table 3.3 for precision-recall and F-score
computations). Exigo has the highest F-score of all methods. Biologically, a good
reconstruction algorithm should infer as many correct edges as possible, in addition
to the criteria that most of the inferred edges should be correct, and the F-score
represents a compromise between these two objectives. Notably, it is expected that
due to true biological redundancy, not only false positives but also true positives will
be found topologically non-essential, albeit in different proportions.
In contrast, when SOS Pruning [38], NET-SYNTHESIS [39] and TRANSWESD
[40] were applied to the same compendium, the original experimental perturbation
results could no longer be reconstructed from the resulting pruned networks (on ave-
rage 50% of interactions for SOS Pruning, 17% for NET-SYNTHESIS and 12% for
TRANSWESD were not reconstructable from pruned networks), thus indicating that
too many edges, or incorrect edges, have been removed (Fig. 3-8 and Table 3.3).
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Exigo-enhanced network inference outperforms state-of-the-
art methods
Recent studies [72] have shown that information from perturbation screens can readily
improve the performance of network inference methods. In fact, methods that incor-
porate topological analysis of perturbation data have performed best ([40, 73] - first
and third place, respectively) in the recent DREAM4 competition [72] for network
inference methods.
To test whether Exigo's topological analysis can improve such network inference
methods, we combined the confidence values from Pinna et al.'s [73], state-of-the-art
network inference algorithm with Exigo (Materials and methods). Briefly, we use the
same input confidence matrix as Pinna et al. and apply Exigo to a thresholded confi-
dence matrix. Then, the entries found to be topologically essential are upweighted by
its confidence value (see Materials and methods for details) and the confidence matrix
is normalized. We tested the performance of the hybrid method on five DREAM4
benchmark networks, and found that it substantially improved performance compared
to previous state-of-the-art network inference methods: 75.413 points against 71.589
points from Pinna et al. (for AUROC and AUPR values of DREAM4 benchmark
networks see Table 3.4). This improvement was observed for all values of threshold
parameter required by Pinna et al. [73] method, indicating that Exigo's topological
analysis contributes novel valuable information.
Notably, while Exigo's approach can enhance network inference methods, it is
not designed for this purpose. Indeed, there is a fundamental difference between
identifying the minimal topology most consistent with perturbation data (as Exigo
aims to do) and the more general problem of network inference. In particular, Exigo's
goal is to identify the set of essential edges that must be preserved across all possible
topologies. It thus provides a valuable additional input that can be used by various
inference algorithms, and improve the quality of networks that they reconstruct.
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3.4 Discussion
We present Exigo, an approach to systematically identify interactions that are topo-
logically unnecessary, find a core network that is consistent with a given perturbation
experiment and characterize the relative importance of topologically essential edges.
Exigo relies on comparing a reference matrix derived from the original network and
with those derived from networks where one edge is missing. Thus, it explicitly lists
the indirect interactions that depend on the removed interaction.
Exigo is a global approach applicable to full networks that, unlike most other pub-
lished methods [36, 38-40], accounts for the indirect effects that the removal of an
edge between one pair of nodes can have on the interaction between another pair of
nodes. For example, existing approaches that rely on transitive reduction [34] would
consider 109 of 253 of the edges in the mammalian network above as candidates for
removal, since removing the edge from node i to j is compensated by indirect in-
teractions between i and j. Yet, only 41 edges are found to be non-essential if we
consider the global effect of edge removal - in the remaining cases, there always exists
a seemingly unrelated pair of nodes k and 1 whose interaction is destroyed by removal
of edge from i to j. This 'global entanglement' illustrates that a naive approach
to transitive edge removal is unrealistic. Furthermore, when constructing the most
parsimonious network in the above example, only 17 edges out of 41 can be simulta-
neously removed, while 24 edges are contained in different degeneracies and there are
multiple different solutions that can be constructed by removing degenerate edges in
different combinations. Conversely, exhaustive enumeration of all possibilities, as in
the TRANSWESD algorithm [40], is computationally intensive, and does not scale
well for realistic biological networks. Thus, Exigo strikes an effective balance between
global analysis and computational limitations, and substantially improves over exis-
ting approaches. In particular, its complexity is polynomial, it relies exclusively on
matrix-based operations (that can be efficiently implemented in e.g., MATLAB, Fig.
3-9) and it avoids any direct paths enumeration techniques. Exigo's current compu-
tational time is 1-2 minutes (on an Intel Core 2 Quad CPU; 2.4 GHz) for networks
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of 100-300 nodes, a realistic scale for experimental perturbation screens. Analysis of
a 1000-node network takes on average 155 minutes (on the same platform as above).
Finally, as perturbation screens of thousands of genes (followed by signature profil-
ing, as in [83]) are now becoming possible, Exigo's approach is fully parallelizable, as
analysis of each edge can be done independently. It thus can be scaled in principle
to genome-size networks. By comparison, a full version of TRANSWESD algorithm
takes several hours for networks of 100-nodes, while their approximate version takes
less than a minute, much like Exigo's exact version.
Furthermore, while we allow indirect interactions of any length to contribute to
the reference matrix, in some circumstances one might prefer considering only paths
shorter than a certain length (for instance, if longer indirect interactions are biologi-
cally unrealistic). In this case, the procedure for finding the reference matrix can be
modified by restricting the number of terms that contribute to the reference matrix in
Eq. 3.2. Finally, Exigo can be extended beyond purely topological considerations by
explicitly considering the confidence weights associated with each interaction. Specif-
ically, given a "composition" rule for determining the confidence of a multi-step path
from the confidences associated with its constituent edges, the convergence opera-
tion can be modified for the space of matrices that have signed confidence values as
individual entries. In this case, the reference matrix would be obtained by threshold-
ing the resulting matrix that contains confidence measures for all direct and indirect
interactions.
Topological analysis can substantially enhance network inference algorithms [72].
To demonstrate Exigo's utility for this purpose, we have integrated it as a 'topological
analysis module' within a state-of-the-art network inference algorithm used in the
DREAM4 challenge [73]. The substantial enhancement in performance gained by
the addition of Exigo illustrates its utility. Future efforts can further enhance such
integration, for example by introducing novel confidence-based metrics for identifying
the most parsimonious graphs or through comparative analysis of different possible
parsimonious networks.
When applying Exigo, it is important to keep some limitations in mind. The core
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networks identified by Exigo are not necessarily the most parsimonious networks: a
group of individually essential edges may still be removable together without perturb-
ing the experimental observability class of the whole network, even though each edge
is individually essential. In its present form, Exigo does not probe such removal of
multiple essential edges, due to computational complexity. However, the same con-
verging transformation can be used to evaluate if such removal leads to a network of
a different observability class. In this sense, Exigo provides a systematic approach
to critical for the identification of parsimonious networks, analogous to power-series
based approaches for studying critical phenomena in statistical physics [84].
In conclusion, we present a novel systematic approach for analysis and interpreta-
tion of large scale gene regulatory networks derived from gene perturbation screens.
Our approach is robust, flexible and computationally efficient, and presents a sub-
stantial and demonstrable improvement to previous methods. Thus it can assist in
the interpretation and follow-up of biological experiments and provides a systematic
framework for topological analysis and comparison of large gene regulatory networks.
While exact construction of the most parsimonious network for a given experimen-
tal observation remains an unsolved mathematical problem, our approach provides a
direct and systematic path for studying the effects of higher order topological effects
(such as degenerate structures) on the structure of the core network.
3.5 Materials and methods
Exigo
There are four major steps in Exigo: for a given input network, (1) Exigo computes
the reference matrix by applying a convergence transformation. This reference matrix
describes all possible (direct or indirect) interactions with their appropriate signs. (2)
Exigo finds all individual non-essential interactions by comparing the reference matrix
of the input network and those of networks where individual interactions have been
removed. (3) Exigo identifies edges contained in various degeneracies and breaks the
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degenerate structure of the solution by leveraging experimental information on the
confidence of each interaction. Exigo overall procedure is the following:
Input: A matrix M, with regulator genes in rows and target genes in columns.
Output: A core matrix coreM, with the identification of individual non-essential
entries and degenerate entries.
1. Find the reference matrix Mreference for MI using equations 3.1 and 3.2
2. Identify all individual non-essential edges
for each edge (ij)
" create M' from M by setting M(i, j) to zero
" compute Mr/eference, the reference matrix for M'
" compare M/eference to Mreference
if Mreference =Mreference
edge (i, j) is non-essential
else
edge (i, j) is essential
end if
end for
3. Identify non-essential edges embedded in degenerate topologies
3.1. order all non-essential individual edges in an arbitrary but fixed order
3.2. start with the network that has the first edge removed and remove the
next edge in the ordered list
3.3. compute the reference matrix of the network with two removed edges,
Mr/eference, and compare it to Mreference
if rIe'erence - Mreference
e the two edges are non-essential even if they are removed simulta-
neously and are not identified as degenerate edges
e remove the three first edges (the former two and an additional one)
in the ordered list and repeat the convergence test of step 3.3
else * the second edge in the ordered list is degenerate
" keep the degenerate edge intact while proceeding to the next edge
and removing it
end if
3.4. repeat steps 3.2 to 3.3 (removing second, third, etc., edge at each iteration)
until going through the list of all individual non-essential edges
3.5. change the list order by placing the last degenerate entry of the list at the
beginning and keeping the rest of the sequence unchanged
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3.6. consider this modified list as your new ordered list and repeat steps 3.2 to
3.5
4. Break degeneracies by using confidence values
4.1. Arrange all degenerate edges in the order of increasing confidence
4.2. Make matrix with the least confident edge removed
4.3. Remove next edge in the ordered list
4.4. Check if reference matrix of modified network is equal to the original one
if equal
go to the step 4.3
else
recover last removed edge and go to step 4.3
end if
Identification of non-essential edges embedded in degenerate
topologies
We use a stepwise, iterative procedure to identify the edges that cannot be removed
simultaneously: (1) We order all the non-essential individual edges in an arbitrary
but fixed order. (2) We start with the network that has the first edge removed (note
that removal of only the first edge is guaranteed not to change the observability class
of the network because each edge has already been determined to be individually
non-essential). We then remove the next edge in the ordered list, use the convergence
transformation to compute the reference matrix of the network with two removed
edges, and compare it to the reference matrix of the original network. (3) If the
perturbed network converges to the original reference matrix, the two edges are non-
essential even if they are removed simultaneously and are not identified as degenerate
edges, at least at this point, and we proceed to remove the three first edges (the
former two and an additional one) in our ordered list and repeat the convergence
test of step (2). (4) If, however, removal of the edges breaks convergence to original
reference matrix, we identify the second edge in the ordered list as degenerate and
keep this edge intact while proceeding to the next edge and removing it. (5) We
then iterate steps (2)-(4) until we go through the complete list of all individually
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non-essential edges. (6) Once we have reached all edges in the list, we change the list
order by placing the last degenerate entry of the list at the beginning and keeping the
rest of the sequence unchanged; we then repeat procedures (2)-(5) considering this
modified list as our ordered list from step (1). Overall, we perform this procedure
no more than n times, where n is the number of edges in the network, which is also
the number of possible cyclic permutations of initial arbitrary ordered list. Fig. 3-10
shows an example of this procedure for the network (I) shown on Fig. 3-2 A.
Complexity Analysis
Reference Matrix computation Complexity. The algorithm continuously mul-
tiplies the adjacency matrix (adjusting the diagonal to 0 at every step to avoid self-
walks) until either the matrix converges (i.e., Mreft_1 = Mreft) or matrix has been
multiplied by itself 2n times (where n is the number of rows/columns in the adjacency
matrix). Thus, given that matrix multiplication takes 0(n 3 ) time, and this operation
is repeated 2n times in the worst case, the complexity of the reference matrix com-
putation is O(2n x n3 ) = O(2n 4).
Core-finding algorithm Complexity. The algorithm first removes all edges in
the network one by one to determine edges whose removal results in a change in the
reference matrix (such edges are dubbed "essential" edges). The complexity of the
algorithm at this step is O(e2n4 ) where e is the number of edges and n is the num-
ber of nodes in the adjacency matrix. Next, the algorithm goes through each of the
found non-essential edges and finds the sets of degenerate edges (i.e., cannot remove
all edges at the same time and preserve the reference matrix). The complexity of
this step is O(enonessentiai2n'). Next, the algorithm finds the most parsimonious set of
edges to preserve. Briefly, this step involves looping through the set of non-degenerate
edges, removing edges one by one, then restarting until each non-degenerate edge has
been removed at least once with respect to all other non- degenerate edges in the set.
The complexity of this step is O(e2on2sentia2n4 ). Thus, the total complexity of this
algorithm is O(e2n4 + enonessentiai2n4 + enonessential2n4 ).
Degeneracy-breaking algorithm Complexity. The algorithm first removes all
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edges in the network one by one to determine edges whose removal results in a change
in the reference matrix (such edges are dubbed "essential" edges). The complexity
of the algorithm at this step is O(e2n4 ) where e is the number of edges and n is
the number of nodes in the adjacency matrix. Next, the algorithm steps through all
non-essential edges in a sorted manner (according to each edges confidence value) and
removes (without replacement) non-essential edges that do not change the reference
matrix in a degenerate manner. The complexity of this step is O(enonessential2n4 )
where enonessential is the number of non-essential edges found using the previous step.
Thus, the overall complexity of the algorithm is O(e2n4 + enonessentiai2n4 ).
Exigo implementation and test datasets
We provide a website (http://www.broadinstitute.org/regev/exigo/) with exe-
cutable scripts that take networks specified in matrix format (perturbed regulators in
rows) and outputs network analysis that includes the list of individually non-essential
edges, list of edges affected by individually essential edges and the list of degenerate
entries on the website. Additionally, on this website one can find documentation with
a practical application of Exigo on all the networks used in our work: DC networks
(sizes 39 x 39 and 155 x 128), small (10 nodes) synthetic network and sixty large (100
nodes) synthetic networks.
Chimeric network inference method
To combine Exigo within the inference method of Pinna et al. [73], we started with
the same confidence matrix as Pinna et al. (the Z-score normalized raw perturbation
matrix WZR) and the same threshold (t = 2), as the one used in the DREAM
challenge (see Table S3 for threshold variations). We set all entries in WZR to 0,
where IWZR| < t and took the sign of the resulting matrix, M, such that all entries
greater than 0 were set to 1 and all entries less than 0 were set to -1 in M. We
applied the degeneracy breaking scheme of Exigo to M to obtain a matrix E. Finally,
we set all non-zero entries in E to their respective confidence values from the WZR,
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and normalized this confidence matrix by the maximum absolute value, according
to the recommendation for DREAM evaluation. The final confidence output from
the degeneracy breaking matrix E and Pinna et al.'s downRank matrix DR was the
arithmetic mean of the entries in both matrices (ChimericConfidenceij = (DRij +
Ej) /2).
Software and datasets used
GeneNetWeaver. We used GeneNetWeaver [82] to sample 60 100-node synthetic
networks and simulate mRNA levels following knock-out of each of the 100 transcrip-
tion factors in each of those networks. We have produced knock-out time-series and
recorded mRNA concentration at 400 s timepoint, assigning a confidence level to each
genetic interaction using z-scores, akin to those used when handling real perturbation
data [4, 6]: we computed z-scores for each interaction across all the knock-outs and,
thus, found corresponding p-values to observe the specific mRNA level upon gene
knock-down. To construct the perturbation graph we recorded only interactions with
a p-value less than 0.05.
SOS Pruning, NET-SYNTHESIS and TRANSWESD. Based on the code
available in the supplement of [38], we applied the SOS (save our signs) pruning
procedure to several synthetic networks. We also downloaded NET-SYNTHESIS
from http: //www. cs. uic. edu/-dasgupta/network-synthesis/ and applied the al-
gorithm of transitive reduction to perturbation graphs. For TRANSWESD, we used
version 9.9 of CellNetAnalyzer downloaded from http://www.mpi-magdeburg. mpg.
de/projects/cna/cna.html.
Mammalian networks. The interaction matrix for the dendritic cell network was
constructed based on Fig. S14B of [6]. The expanded interactions matrix and confi-
dence values were taken from Tables S6 and S7 of [6].
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3.6 Figures and tables
A Output genes B
A B C A A
C C
Experimental Possible genetic
result regulatory networks
Figure 3-1: Experimental perturbation networks. Shown are a typical output of
a gene perturbation screen (A) and two alternative networks (B), either of which can
produce the same experimental perturbation result. Red and blue square, respectively:
perturbation of the regulator decreases or increases the expression of the output gene. Red
arrow activation; blue blunt edge repression.
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Figure 3-2: Exigo. (A) The sequence of steps in Exigo: given an experimental pertur-
bation network (I), Exigo derives a reference matrix (II) which includes all possible (direct
or indirect) interactions. It then identifies all individual non-essential interactions (III), fol-
lowed by determining which edges are contained in degeneracies (IV). In each panel, shown
are a network view (top), and the corresponding matrix in either color code (middle) or
numerical (bottom) form. Red (blue) arrow/cell: activating/repressing interaction. Solid
colors: essential interaction; faded color: inessential/removed interaction. In bottom ma-
trix: 1 activation, -1 inhibition, 0 no interaction. (B) Deriving the reference matrix.
Shown is the process of deriving a reference matrix by applying a convergence transforma-
tion to the network (I) from panel A. The original network I is shown on the top left, along
with its corresponding adjacency matrix (left, bottom), M 1. The reference matrix (right,
grey shading) is obtained as a weighted and thresholded sum of matrices representing self-
avoiding random walks of different length (Mi). Each matrix can be constructed iteratively
from M 1 by using the rules shown on the figure and described in detail in the text. Bold
blue paths on the networks above M2 and M 3 show indirect interactions of length 2 and
3, respectively that are computed in the transformation and contribute to the reference
matrix. E(.) designates a thresholding function theta that is applied to each element of
the matrix obtained by summation of all indirect-effect matrices Mi in order to obtain the
reference matrix.
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Figure 3-3: Comparison between the path matrix and the reference matrix generated by
Warshall's and Exigo algorithms, respectively. Red arrow - activation; blue blunt edge -
repression.
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Figure 3-4: Application of Exigo to a mammalian network. (A) Results of apply-
ing Exigo to the regulatory network controlling activation of dendritic cells in response to
LPS. Shown is a 39 x 39 experimental perturbation network (rows: perturbed regulators,
columns: expression targets; red: activation; blue: inhibition; white: no interaction). Bold
black borders encapsulate interactions that have been found individually non-essential (de-
generate or not), and hatched entries indicate the ones that are contained in degeneracies.
(B) Distribution of coherent and incoherent feedforward loops identified in the input ex-
perimental network (exper, dark left bar) and in the core network after confidence-based
degeneracy breaking (core, light right bar). Note that the distribution remains virtually
the same while the absolute number of loops decreases substantially.
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Figure 3-5: The Exigo procedure consists of two major steps: (1) identification of all
individually non-essential interactions and finding degenerate edges among individually non-
essential interactions; and (2) finding a minimal core network by breaking degeneracies
based on the experimentally measured confidence values. Here we show results of applying
Exigo to the regulatory network controlling activation of dendritic cells in response to LPS
after breaking degenerate entries by the use of interaction confidence values (Note that
Fig. 3-4 of the main text shows the network before degeneracy breaking, i.e., after step 1
only). Shown is a 39 x 39 experimental perturbation network (rows: perturbed regulators,
columns: expression targets; red: activation; blue: inhibition; white: no interaction). Bold
black borders encapsulate interactions that have been removed to produce the final core
network.
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Figure 3-7: Performance of different network analysis methods (Exigo (top), SOS Pruning
[38] (middle top), NET-SYNTHESIS [39] (middle bottom) and TRANSWESD [40] (bot-
tom)) on the same synthetic network of 10 edges. Red arrows: activating interactions,
blue blunt arrows: repressing interactions. Shaded arrows: interactions that were found
non-essential by the indicated method. Both SOS Pruning and NET-SYNTHESIS incor-
rectly remove edges that are essential for observing the experimental screening results.
TRANSWESD removes interactions such that interactions reconstructed based on the core
network actually have opposite signs to the original ones: for example, upon removal of
inhibiting interaction E - G, the shortest path indirect interaction is actually an activating
one. Similarly, when removing E -+ F, the reconstructed interaction is actually inhibiting.
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Figure 3-8: Comparison of the performance of different methods on simulated experi-
mental networks derived from a compendium of 60 synthetic 'ground truth' networks (100
nodes each). For each method, shown are the fraction of experimental edges explained by
the core networks produced (blue), the fraction of true positive edges (based on the ground
truth network) that are retained in the core networks (dark red) and the fraction of false
positive interactions in the core networks (yellow). By definition, Exigo always explains
all of the available experimental observations. It also outperforms in the fraction of true
positives retained. Note that some experimental edges are not explained by core networks
produced by SOS Pruning and NET-SYNTHESIS. This means that neither direct nor in-
direct interactions on the core networks produced by SOS Pruning or NET- SYNTHESIS
can recapitulate the effect of some of the experimental edges indicating that inconsistency
have been introduced during the parsing process. Note that Exigo core network is always
consistent with experimental network (see also Table 3.3 and Fig. 3-7).
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Figure 3-9: Timing results (Intel Core 2 Quad CPU; 2.4 GHz) for applying MATLAB
coded degeneracy-breaking version of Exigo to networks of various size.
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and test convergence the same procedure the same procedure
AC: 0 0 0 BC: 0 0 0 A C: 0 0 0
AD: -1 0 0 AC: -1 -1 / BC: -1 CO -1
BC: -1 -1 (D AD: -1 -1 0 AD: -1 -1 0
/ X I/ X /i/ X /
BC is within a degeneracy AC is within a degeneracy BC was already identified!
(A) (B) (C)
Figure 3-10: Illustration of the mechanism to identify degenerate edges for the network
described in Fig. 2 of the main text (Materials and methods). First (A), the non-essential
individual edges (AC, AD, BC) are ordered arbitrarily and then this order is fixed. The first
edge is then removed, which is indicated by 0 in panel (A). Removal of the first edge (AC)
does not change the observability class of the network which is indicated by the check- mark
below the column on the panel (A). Next, we remove the two first edges in the ordered list
(AC and AD), as indicated by 0 in the second column in panel (A). We find that removal of
the first two edges does not alter the observability class and thus put a check-mark below
this column and proceed to remove also the third non-essential edge (thus, AC, AD and
BC are removed). In this situation we find that observability class changes indicating that
BC, while being individually non-essential, is contained within a degeneracy. We next (B)
modify the order of edges to put BC atop of the list and repeat the procedure described
above to find that AC is contained within a degeneracy and modify the list order to the one
shown on panel (C). Finally (C), we find edge BC as the degenerate one, which has already
been identified and, thus, we stop the procedure.
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I _IIAverage | Std. Deviation] Median
True network Total edges 285.25 7.56 288.00
Perturbation (experimental) Total edges (TP same 274.63 35.02 276 (126+2)
network sign + TP opp signs) (125.15+2.45) (13.97+1.37)
Precision 0.468 0.045 0.464
Recall 0.448 0.055 0.444
F-score 0.456 0.042 0.448
NET-SYNTHESIS (Kachalo et Total edges (TP same 124.65 10.87 124 (90+0.5)
al., 2008) sign + TP opp signs) (89.55+0.7) (8.77+0.91)
Unexplained Experi- 46.00 45.98 46.12
mental Interactions
Precision 0.725 0.054 0.715
Recall 0.317 0.033 0.317
F-score 0.440 0.039 0.440
SOS pruning (Tresch et al., Total edges (TP same 97.92 12.97 98 (43+1)
2007) sign + TP opp signs) (44.15+0.85) (6.59+0.82)
Unexplained Experi- 156.98 21.49 157.00
mental Interactions
Precision 0.462 0.058 0.457
Recall 0.158 0.026 0.153
F-score 0.235 0.033 0.229
TRANSWESD (Klamt et al., Total edges (TP same 130.58 10.09 129 (94.5+1)
2010) sign + TP opp signs) (93.67+0.75) (9.09+0.93)
Unexplained Experi- 33.77 22.67 28.00
mental Interactions
Precision 0.724 0.059 0.722
Recall 0.331 0.035 0.335
F-score 0.454 0.042 0.461
EXIGO Core Network (before Total edges (TP same 201.63 29.20 206.5 (117+1)
degeneracy breaking) sign + TP opp signs) (115.95+1.73) (12.41+1.30)
Unexplained Experi- 0.00 0.00 0.00
mental Interactions
Precision 0.590 0.065 0.583
Recall 0.413 0.050 0.418
F-score 0.483 0.042 0.479
EXIGO Core Network (after Total edges (TP same 183.92 25.73 186.5 (114+1)
degeneracy breaking) sign + TP opp signs) (113.93+1.28) (11.91+1.14)
Unexplained Experi- 0.00 0.00 0.00
mental Interactions
Precision 0.632 0.066 0.627
Recall 0.405 0.048 0.409
F-score 0.491 0.043 0.485
Table 3.3: Statistics for 60 synthetic 100-node networks used in this study. True networks row cor-
responds to the networks sampled from yeast regulatory networks by GeneNetWeaver; perturbation
network row corresponds to the experimental networks constructed based on the kinetic simulations
ran by GeneNetWeaver (page 89); subsequent rows correspond to the networks that result from
application of Exigo and other methods to the perturbation networks. Additional row in the table
describes the number of experimental edges that cannot be reconstructed from core networks pro-
duced by each method. A non-zero number of non-reconstructable experimental interactions means
that this number of interactions is reconstructed incorrectly from core networks obtained by the
pruning methods (SOS Pruning, NET-SYNTHESIS and TRANSWESD) indicating that inconsis-
tency have been introduced during the parsing process. Specifically, in case of TRANSWESD, it
means that incorrectly reconstructed interactions have opposite signs to the real ones. This is due
to the failure of TRANSWESD to account for shorter indirect interactions of opposite signs when
identifying the core network (a simple example of such situation is provided on Fig. 3-7). SOS
Pruning and NET-SYNTHESIS fail to reconstruct the experimental network for the same reason as
TRANSWESD and also simply due to excessive removal of essential interactions (again, a simple
example of such situation is provided in Fig. 3-7). Exigo core network is always consistent with the
experimental network.
100
Score 75.413 71.589 71.297 64.715
AUPR
Network 1 0.63684 0.53607 0.512 0.49
Network 2 0.37775 0.37711 0.396 0.327
Network 3 0.40014 0.38983 0.38 0.326
Network 4 0.3851 0.34943 0.372 0.4
Network 5 0.21966 0.21332 0.178 0.159
AUROC
Network 1 0.91481 0.91363 0.908 0.87
Network 2 0.80147 0.80149 0.797 0.773
Network 3 0.8331 0.83304 0.829 0.844
Network 4 0.84228 0.84163 0.844 0.827
Network 5 0.75936 0.75916 0.763 0.758
Table 3.4: Comparison of network inference algorithms on benchmark networks of the
DREAM4 challenge. The 'chimeric algorithm' that includes the topological analysis module
of Exigo outperforms other state-of-the-art network inference methods. Total score, AUPR
and AUROC are computed using DREAM4 evaluation scripts.
Downrank (t = 2) DownRank DownRank (t DownRank (t -
+ Exigo (DREAM4 Set- 2.5) 2.5) + Exigo
tings)
Score 75.413 71.589 79.279 81.191
Table 3.5: Performance of chimeric network inference method shown for two threshold
choices: t = 2 corresponds to the threshold used by Pinna et al. in the DREAM4 competi-
tion and t = 2.5 corresponds to the optimal threshold for DREAM4 benchmark networks.
In both cases information added by topological analysis with Exigo improves performance.
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Pinna et al. Pinna et al. Team 296 Team 515
(DREAM4) + (DREAM4 (second place) (third place)
Exigo best)
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Chapter 4
Inferring transcriptional and
microRNA-mediated regulatory
programs in Diffuse Large B-cell
Lymphoma
4.1 Abstract
Diffuse Large B-Cell Lymphoma (DLBCL) is the most common lymphoid malig-
nancy in adulthood. Although some genetic abnormalities have been related to the
pathogenesis of this disease, the full identity of dysregulated cellular pathways is still
unknown. A system-level dissection of regulatory mechanisms using heterogeneous
datasets can help identify, among other things, new previously uncharacterized regu-
latory elements and the molecular pathways they target and whose disruption might
lead to tumorigenesis. However, integrating different data sources brings many chal-
lenges, since they may have different quality and informativity. We used Module Net-
works to identify modules of co-regulated genes and integrate datasets from multiple
high-throughput assays: gene expression micro-arrays, DNA copy-number SNP ar-
rays, and microRNA arrays. Our analysis associates miR152 and CD63 with survival,
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links MYCBP and COPS5 with a module of genes enriched for oxidative phospho-
rylation and mitochondrial functions, and CREBL2 with a glycolysis module. This
analysis expands the knowledge about causal and combinatorial relationships that
characterize molecular signatures in DLBCL and, generally, provides a systematic
approach for the integration and analysis of different types of datasets.
4.2 Background
Understanding the molecular mechanisms that drive tumorigenesis is a fundamental
question in biomedical research. Genomics research in the past decade has shown
that cancers harbor unique transcriptional signatures that distinguish them from
other cancer types and sub-types and from normal tissue, and that have tremendous
diagnostic and prognostic value [85]. More recently, large-scale projects, such as The
Cancer Genome Atlas (TCGA), are also characterizing the cancer genome for large-
scale genetic aberrations and coding mutations [47]. However, in most cases, we lack
a genome-scale understanding of the mechanisms that 'translate' these genetic aber-
rations to transcriptional changes, and the role that transcription factors, miRNAs
and other regulatory genes play in this process. For this reason, there has been an
increased interest in approaches that provide a systems-level view of the components
and the properties of the system. To this end, integrating data from different sources
has become an important part of research in genomics [86].
In the past few years, some algorithms have been developed to integrate paired
gene expression profiles and somatic copy number alterations (CNAs) information
on the same patients (reviewed in [87]). CNAs, which are differences in the number
of copies of multi-kilobase segments of the genome, are a major source of genetic
diversity, with several variants now conclusively linked to human disease. While we
were working on this project, Akavia et al. [16] published CONEXIC, a Bayesian
algorithm that identifies candidate driver genes in cancer and links them to gene
expression signatures they govern by integrating copy number and gene expression.
CONEXIC is inspired by the Module Networks algorithm [3] and uses a score-guided
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search to identify the combination of modulators that best explains the behavior of a
gene expression module across tumor samples and searches for those with the highest
score within the amplified or deleted regions. The algorithm was applied to data from
melanoma cell lines, where it correctly identified known drivers and connected them to
their known targets. Integrative analysis of CNAs and gene expression has also been
used to identify tumor subtypes or patient groups that have different characteristics
including patient survival, and response or resistance to therapy [88, 89]. In addition,
other computational approaches have been proposed that identify miRNA regulatory
modules by integrating expression profiles of miRNAs and mRNAs (e.g. [90, 91]). To
our knowledge, very few studies have integrated CNA, miRNA and gene expression
profiles simultaneously. An example of such integrative analysis is proposed in [92],
where non-negative matrix factorization-based clustering [93] of mRNA expression
data was used to identify molecular subgroups of medulloblastoma; DNA copy num-
ber, miRNA profiles, and clinical outcomes were then analyzed for each. Here, we use
these heterogeneous datasets to learn an integrative module network that advances
the molecular characterization of Diffuse Large B-cell Lymphoma (DLBCL).
DLBCL is clinically, morphologically and genetically a heterogeneous group of
malignant proliferations of large lymphoid B cells, and accounts for 30 to 40% of
newly diagnosed lymphomas [94]. Based on expression profiling studies, primary
DLBCLs have been categorized into several tumor subtypes [95], including B-cell re-
ceptor/proliferation (BCR), oxidative phosphorylation (OxPhos) and host response
(HR) [96]. The first subset, BCR, is enriched for genes involved in cell-cycle reg-
ulation, DNA repair, cell division and B-cell receptor signaling, and is associated
with BCL6 gene rearrangements. The OxPhos signature includes genes involved in
oxidative phosphorylation, suppression of apoptosis, and mitochondrial and protea-
some function, and it is more frequently associated with the translocation t(14;18),
affecting the antiapoptotic gene BCL2. Finally, the HR signature is enriched for
genes involved in T-cell receptor and cytokine signaling, natural killer cell activation,
dendritic cell maturation and chemotaxis. Studies of the diversity and clinical im-
pact of the BCR and HR signatures have made the transition from transcriptional to
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functional analysis, but little is still known for the OxPhos subset.
Our integrative analysis provides an unbiased way for identifying drivers that best
account for the behaviour of sets of genes. We use Module Networks to infer modules
of expression data and then learn regulatory programs for each module, consisting of
regulator genes, miRNAs and CNAs (Fig. 4-1). The method identified 100 modules
associated with 231 regulator genes (40 of which are in amplified or deleted regions),
108 miRNAs and 39 CNAs. Novel observations include the identification of CD63
and miR152 as biomarkers for predicting survival, a possible role of MYCBP and
COPS5 in oxidative phosphorylation and mitochondrial functions, and the association
of CREBL2 with glycolysis. Our model raises concrete testable hypotheses which can
be tested by perturbation experiments, helping to advance the characterization of
DLBCL and its subtypes.
4.3 Learning of a Module Network for DLBCL
We employed the Module Networks algorithm [3] to learn a network model for DLBCL
that aims to explain changes in gene expression in tumors by underlying molecular
and genetic changes. This model associates modules of co-expressed genes with reg-
ulatory programs that use a combination of regulator' profiles (genetic aberrations,
regulator genes and microRNA expression) to predict these expression changes. It
raises concrete testable hypotheses which can be tested by perturbation experiments.
Module Networks is a probabilistic graphical model [11] that automatically infers
modules of co-expressed genes and their shared regulatory programs. A regulatory
program uses the expression level of a set of regulators to predict the condition-
dependent mean expression of the genes in a module. The algorithm uses an iterative
learning procedure using the Expectation Maximization (EM) algorithm. Each ite-
ration consists of two steps: an E-step and an M-step. In the M-step the procedure
is given a partition of the genes into modules and learns the best regulatory program
(as a regression tree) for each module. In the E-step, given the inferred regulatory
programs, it re-assigns each gene tothe module that best predicts the gene's behavior
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(it does not assign a regulator gene to a module in which it is also a regulatory input,
directly or indirectly). The target function is the Bayesian score, derived from the
posterior probability of the model (see [97] for a detailed description of the algorithm).
The regulatory program is chosen from a pre-defined set of candidate regulators.
In this study we used three different types of datasets to build a comprehensive
map for DLBCL. From the publicly available microarray-based transcription dataset
of 176 primary DLBCLs generated using Affymetrix U133A and U133B platforms
[96], we used 110 of these samples for which paired mRNA and miRNA profiles were
available. After robust multichip average (RMA) processing, using Affymetrix' abso-
lute call data, genes with "present" calls in fewer than 80% of arrays were discarded
(eliminating 17,215 [77%] of 22,283 probe sets) so reducing genes whose expression
were largely in the noise range. We further eliminated probe sets with no Entrez gene
identifier and averaged probes mapping to the same gene. This resulted in a final
dataset with 3,716 genes. Regarding the miRNA data, which was generated with Lu-
minex, we used a list of 155 miRNAs. The chromosomal copy number alterations were
collected from the HD SNP arrays of sixty-two of the 176 primary DLBCL genomic
DNAs, as described in [98].
We initially considered three strategies to integrate these heterogeneous datasets:
(1) search for one Module Network model whose regulatory programs were chosen
from all types of features simultaneously; (2) search for separate Module Network
models for each feature type; (3) search for one Module Network for one feature type
and then learn extra regulatory programs for each module using the other feature
types. However, the first strategy did not work well, since the measurements were
obtained by different technologies and there was a consistent bias towards choosing
regulators from the same data type of the genes in the modules. We found the second
strategy very unstable for an integrative framework analysis, as the three module
networks learned (one for each data type) generated different modules of genes. We
decided to pursue the third strategy, which overcomes these limitations.
First, our approach consisted in applying the Module Networks procedure on the
mRNA dataset, which consisted of 110 samples and 3,716 genes. This list included
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397 genes with a regulatory potential (transcription factors and signaling molecules)
that were used as input candidate regulators for Module Networks. We initialized the
algorithm systematically from 10 to 250 modules (in increments of 10), and chose the
model whose Bayesian score was 85% of the best score (Fig. 4-2). The chosen model
consisted of 100 modules (Fig. 4-3). These modules have a variable number of genes,
with a median size of 35 genes. Twenty-five percent of the clusters have less than 22
genes and 75% have less than 50 genes. The global view of the modules is presented
in Fig. 4-4 and was generated by calculating the average expression over all genes
in each module. Furthermore, for each of these 100 modules, we learned another
two regulatory programs: one using all 155 miRNAs as candidate regulators and
another one using 45 CNAs discrete profiles. These profiles, determined by GISTIC
[99] according to a defined amplitude threshold (Fig. 4-5), are discrete, so that a
'0' indicates that the copy number of the sample was not amplified or deleted, a '1'
indicates that the sample had low-level copy number aberrations, and a '2' indicates
that the sample had high-level copy number aberrations.
4.4 Modules are enriched for specific processes and
functions
In order to identify the potential functional role of assigned regulators, we inspected
the gene set enrichment of the target modules (using the Genomica software). It is
expected that modules are likely enriched with genes whose expression is biologically
affected by the regulators. Thus, the processes represented by genes in a module may
suggest how a regulator gene, miRNA or CNA change the cellular physiology and
contribute to the oncogenic phenotype. We collected functional sets of genes from
GO [100] and MSigDB (C2-CGP: curated chemical and genetic perturbations) [101]
and predicted miRNA target genes sets from MSigDB (C3.MIR) [101] and TargetScan
[102]. TarBase [103] provided a manually curated collection of experimentally tested
miRNA targets in human. In addition, we used the hematopoietic gene expression
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differentiation map (DMAP) [12] to provide us sets of genes that were significantly
over- or under-expressed across lineages in hematopoiesis (and hence relevant to DL-
BCL), and gene sets associated with human ES cell identity collected from microarray
studies [104], since human ES signatures are often related to poor prognosis in tumors.
A total of 78 modules have at least one functional category overrepresented at the
0.05 significance level (FDR corrected P-values). In total, 550 different categories are
overrepresented, some of which are shown in Fig. 4-6. For example, modules 782,
800, 848 and 1087 are mostly enriched for oxidative phosphorylation and mitochondria
related genes (P-values 1.96 x 10-11 and 8.21 x 10-7, respectively), while modules 794
and 1177 are statistically enriched for cell cycle and DNA replication genes (P-values
1.23 x 10-5 and 4.62 x 10-8, respectively). Modules 1129 and 1207 are enriched for
immune response genes (P-values 4.19 x 10-12 and 1.77 x 10-, respectively), module
1123 for inflammatory response genes (P-value 3.37 x 10-5), and modules 963 and 999
for extracellular matrix genes (P-value 1.96 x 10-" and 8.21 x 10-7, respectively).
Several modules are statistically enriched for other functional categories like ribosome
(modules 695, 1041, and 1053, with P-value 2.37 x 106, 1.13 x 10-20 and 6.44 x
10 -50, respectively), splicing (module 1117, with P-value 2.09 x 10-6), endoplasmatic
reticulum (module 926, with P-value 2.04 x 104) and glycolysis (module 969, P-value
4.19 x 10-5).
4.5 Regulatory programs overview
Of the set of candidate regulators, 231 out of 397 were found to regulate at least
one module in the inferred network, 40 of which are in amplified or deleted regions.
Furthermore, the model associated 108 miRNAs with the modules and 39 CNAs. In
particular, 57 regulator genes, 35 miRNAs and 23 CNAs were chosen as top regulators
(Fig. 4-7). Among these sets, COPS5, miR-30e-50 and deletion peak in region 2q33.3
were the most frequent choices (15, 13 and 33 times, respectively).
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4.6 Potential regulators with a role in DLBCL
To show the approach's ability to reproduce diverse features of regulatory programs,
we discuss some of the key modules identified.
Inflammatory response module
The inflammatory response module (1123, fig. 4-8) is inducted by CEBP-#, a gene
important in the regulation of genes involved in immune and inflammatory responses;
in particular, it has been shown to bind to the IL-1 response element in the IL-6 gene,
as well as to regulatory regions of several acute-phase and cytokine genes. CEBP-3
is a crucial regulator of hematopoiesis, it belongs to the family of basic leucine zip-
per (bZIP) transcription factors, and its main function has been implicated to be in
control of myeloid differentiation [105]. On the other hand, the inferred miRNA regu-
latory program specifies miR-223 as the module's top (activating) regulator. miR-223
is a hematopoietic specific microRNA with crucial functions in myeloid lineage devel-
opment and it has been shown to target CEBP-# mRNA 3' UTR [106]. The choice of
these top regulators is consistent with the module's enrichment for genes induced in
the granulocyte/monocyte progenitor (GMP) and common myeloid progenitor (CMP)
clades (P-values 4.96 x 10-1 and 1.33 x 10-7, respectively), as well as in monocyte
and granulocyte lineages (P-values 1.21 x 10-11 and 2.19 x 10-4 , respectively).
Cell Cycle and DNA replication modules
One of the fundamental traits of cancer cells is their ability to sustain chronic prolifer-
ation. While normal tissues control the production and release of growth-promoting
signals that instruct entry into and progression through the cell growth-and-division
cycle, these signals are deregulated in cancer cells. In DLBCL, the "BCR/proliferation"
cluster identified in [96] had abundant expression of cell-cycle regulatory genes. Sim-
ilarly, module 1177 from our model, is enriched for cell cycle and DNA replication
genes (P-values 4.62 x 10~' and 5.58 x 10-7). In agreement with this finding, the
module is induced by RNASEH2A (ribonuclease H2, subunit A), a gene that en-
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codes a protein that participates in DNA replication, and by PBK (a.k.a. TOPK),
a mitotic kinase that enhances Cdkl/cyclin B1-dependent phosphorylation of PRC1
and promotes cytokinesis. The miRNA regulatory program identifies miR-20a and
miR-106b in the first and third levels of the decision tree, respectively. Ivanovska et
al. [107] have shown that miR-106b family members contribute to tumor cell pro-
liferation in part by regulating cell cycle progression and by modulating checkpoint
functions. Furthermore, miR-20a and miR-106b (together with miR-17) are known
to act in concert to modulate E2F activity on cell cycle arrest during neuronal lin-
eage differentiation of unrestricted somatic stem cells from human cord blood (USSC)
[108]. The second level regulator of this module predicted by the model is miR-26b
that, even though not implicated in the previous study, has been shown to cooperate
with their host genes to block the G1/S-phase transition by synergistically activating
the pRb protein [109]. These findings suggest that miR-20a, miR-26b and miR-106b
may act in concern to regulate cell cycle in DLBCL.
Also associated with these biological functions is module 794. It is primarily
regulated by RACGAP1, a gene known to be up-regulated in B cell lymphoma tumors
expressing an activated form of MYC [110], and by miR-30e-5p, whose induction
represses the module genes' activity.
Extracellular matrix module
Extracellular matrix (ECM) components have been implicated in tumor growth, pro-
gression, and metastasis in lymphoid malignancies [111]. Our model associated NBL1
and miR-152 with modules enriched for ECM-related genes, cell adhesion and angio-
genesis. NBL1 is a transcription factor that may function as an inhibitor or repressor
in cell growth and/or maintenance, and plays a role in the negative regulation of the
cell cycle.
Although strategies aiming at inducing modifications in the ECM components
would be hard to conceive, given the high redundancy of the cellular dynamics leading
to ECM regulation, ECM-related cues (such as miRNAs) should be taken into account
as potential cancer-related markers for prognosis [111].
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Oxidative phosphorylation and glycolysis modules
While an oxidative phosphorylation subtype has been previously identified in DL-
BCL, the regulatory mechanisms associated with this cancer subtype are still un-
known. Our model associates module 782, enriched for oxidative phosphorylation
and mitochondrial functions, with regulation by the factors MYCBP and COPS5
(Fig. 4-9). These two factors were previously associated with survival and oxidative
metabolism in breast cancer [112, 113], suggesting a possibly general mechanism. In
fact, in [112], it is found that the mitochondrial signature in breast cancer is induced
by overexpression of MYC or MYC plus COPS5, but not COPS5 alone. MYC is a
proto-oncogene that encodes a transcription factor involved in apoptosis, proliferation
and the overall regulation of hematopoietic homeostasis [114]. It has been identified
in several studies as highly prognostic in DLBCL [115-119] and its over-expression
is often associated with malignant transformations. The MYCBP gene encodes a
protein that binds to the N-terminal region of MYC and stimulates the activation of
E box-dependent transcription by MYC. A second level regulator in module 782 is
RAPIB, a small GTPase, and the module itself includes gene RAP1A. Members of
the RAS-like small GTP-binding protein superfamily are known to regulate multi-
ple cellular processes including cell adhesion and growth and differentiation, and one
study has actually reported the role of this gene in the amelioration of high gluco-
seinduced injury and normalization of mitochondrial functions [120]. While COPS5
(a.k.a. CSN5) was selected as top regulator of module 782, COPS4, another subunit
of the COP9 (constitutive photomorphogenic) signalosome (CSN), is a member of the
module. The CSN complex is composed of eight subunits and is a highly conserved
protein complex that is known to regulate processes such as cell cycle progression and
kinase signaling.
Some cancer cells preferentially metabolize glucose through aerobic glycolysis, a
phenomenon known as the Warburg effect [121]. Module 969 associates CREBL2
(cAMP responsive element binding protein-like 2) with target genes enriched for gly-
colysis (e.g. ALDOA, GPI and PKM2) and for up-regulated marker genes that dis-
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tinguish DLBCL from follicular lymphoma (FL) samples, namely HSPCB, ALDOA,
PKM2 and HMGA1. Our finding associates high expression of CREBL2 with the re-
pression of genes with a glycolytic function. In addition, CREB3L2 shows in the third
level of the regulation program. These findings suggest that genes encoding proteins
of the CREB-family may be involved in regulating glycolysis. Interestingly, miRNAs
can mediate fine-tuning of the cancer-associated glycolytic pathways either directly
or at the level of oncogenes [122]. Our model associates let-7c, a miRNA known to
be important in cell growth, with the glycolysis module, regulated by CREBL2.
4.7 Regulators associated with survival and "con-
sensus cluster"
Our integrative analysis allows to systematically search for genes associated with
survival. Given that the regulatory program is described by a decision tree, we could
look at each first split (root) and assay the probability of survival for patients on each
side of it. These two survival curves are compared using a log-rank test of the null
hypothesis of a common survival curve. This strategy for finding association with
an external phenotype can provide powerful results without the need of testing every
gene assayed. In total, six modules show a first split in the regulatory program that
is statistically significant with survival (FDR < 0.25, Table 4.1).
Worth noting, is the association of poor prognosis in DLBCL patients with high
expression of CD63 (Fig. 4-10). The protein encoded by this gene mediates signal
transduction events that play a role in the regulation of cell development, activation,
growth and motility. It is a cell surface glycoprotein that is known to complex with
integrins and that may function as a blood platelet activation marker. Interestingly,
CD63 has already been shown to be a biomarker for predicting the prognosis in earlier
stage of adenocarcinomas of lung [123]. Module 1075, regulated by CD63 is enriched
for immune response genes. Interestingly, is also enriched for up-regulated genes in
B-CLL (B-cell chronic leukemia) patients expressing high levels of CD38 and ZAP70,
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which are associated with poor survival.
In addition, module 716 strongly associates BCL6 expression with a better prog-
nosis, a finding that has been reported in the literature [124]. BCL6 is the most
commonly involved oncogene in DLBCL and its depletion or blockade in primary
DLBCL samples or human DLBCL cell lines causes cell death, suggesting that these
tumors are often addicted to this oncoprotein and need its continuous function for
survival [125, 126].
Also worth noting is module 1201, that associates high expression of ZMYND11
(also known as BS69) with poor survival. This nuclear protein has been shown to
be a transcriptional repressor through interacting with other proteins like c-Myb or
N-CoR [127, 128].
Also, several modules associate miRNAs with disease prognosis (table 4.1). For
example, high expression of miR-152 (a miRNA associated with modules enriched
for ECM genes) predicts poor prognosis in both modules 963 and 999 (p< 0.0032,
FDR=0.07).
Furthermore, to relate our modules to previous expression-based classifications of
DLBCL, we studied whether any of the regulatory programs' first split correlated with
a consensus cluster (OxPhos, BCR, HR), a sub-grouping of tumors identified in [96].
We found that module 1207, enriched for immune system genes, is the most related
to HR (P-value 1.07 x 10-, two-tailed Fisher's exact test with FDR correction).
Also, modules enriched for oxidative phosphorylation genes (782, 800, 848, 1087) are
highly related to the OxPhos consensus cluster (P-values 3.33 x 10-7 , 8.73 x 10-7,
3.33 x 10-7, 2.22 x 10-, respectively); however, the most statistically significant split
refers to module 1165 (P-value 2.09 x 10-') which has a member of RAS oncogene
family, RAP2C, as top regulator.
These results show that our approach, by consistently isolating a small group
of relevant predictor genes from high-dimensional microarray datasets, efficiently re-
duces the amount of tests required to assess survival prognosis if this handful of
predictor variables were not known.
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4.8 Association between copy number aberrations
and modules
In order to understand the functional importance of the genetic alterations in DLBCL,
we looked for regulatory programs with CNAs as candidate drivers. In total, 39 of
the 45 CNAs were chosen, with 23 assigned as top regulators. The only copy number
alteration that was selected as a top regulator of a module and that is also associated
with survival is a deletion peak in region 7q34 (p=0.0014, FDR=0.13). It is the
top regulator of the inflammatory response module (1123, fig. 4-11), already referred
above (fig. 4-8)). This deletion peak contains the genes PRSS1, PRSS2 and PRSS3P2,
trypsinogen genes that are localized to the T cell receptor beta locus on chromosome
7.
Among the altered regions, there are in total seven gene deserts. For example,
the most frequent aberration in our model was deletion peak in region 2q33.3, a gene
desert that would be interesting to further investigate. Generally, these regions appear
to be depleted of conserved elements, which is not surprising since they are in gene
deserts. A total of ~ 9600bp are in the conserved regions (- 1.1% of the regions),
where in random genomic regions we would expect to get ~ 4.5%. Interestingly, one
of the hits is in deletion peak in chromosomal region 2p16.3 and overlaps with a large
intergenic noncoding RNA.
The CNAs did not split the gene expression in the modules as clearly (see e.g.
4-11B) as when we used mRNA or miRNA profiles for the regulatory programs (an
ideal signature would be, for example, the upregulation of target genes when a region
is amplified). This problem may be due to the distinct nature of the two datasets
(discrete vs. real-valued measurements). Therefore we considered an alternative
approach to study driver alterations. We looked for genes in the regulatory programs
that were located in amplified or deleted regions, since the same gene may be targeted
genetically (amplified/deleted) or epigenetically (up/down regulated). We found that
40 of the 231 regulator genes that were associated with at least with one module by
Module Networks are in amplified or deleted regions. In particular, the following
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genes and were chosen as top regulators in regulation programs: BCL6 (module 716),
CD63 (modules 860 and 1075), CREBL2 (modules 920 and 969), MINKi (modules
740, 842 and 1017), DKFZP564K0822 (module 1111) and G1O (module 1267).
Overall, the integration of CNAs with gene expression profiles can give insights of
how the malignant phenotype relates to genetic aberrations from which it is likely to
have originated.
4.9 Design of experimental validation of biological
findings
We decided to focus on the glycolysis and the oxphos/mitochondria modules for fur-
ther validation given the known role of the modules' regulators. In order to test
whether the predicted regulators for these modules have a functional role, we suggest
a few experiments. First, we looked for cell lines that were high or low expressed
in these contexts. From the Broad-Novartis Cancer Cell Line Encyclopedia [129] we
collected two gene sets, with the genes in modules 782 and 969, comprising 16 cell
lines representative of the histology subtype DLBCL. We performed a Kolmogorov-
Smirnov (K-S) test on the expression of the probes in these two gene sets relative
to background of all probes on array. We then sorted the cell lines by the P-values
of the test and scored the genes by correlation to the K-S P-value vector. Then
the genes were sorted by the correlation values. From these results we suggest to
use cell lines SUDHL5, NUDHL1, SUDHL4, Pfeiffer, A4FUK to knockdown genes
COPS5, COPS4, MYCBP, MYC, CREBL2, CREB3L2, RAP1A, RAPIB, and mea-
sure growth and gene expression. These experiments will test whether cell growth
and signature genes' expression are altered after these knockdowns in these cell lines.
These experiments are ongoing.
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4.10 Conclusion
In the past few years, the importance of data integration has increased, due to the
rapidly increasing amount of genomic and other high throughput data. However,
data from different sources are subject to different noise levels due to difference in
technologies, platforms and other systematic or random factors affecting the exper-
iments. Thus, data might have different qualities and a naive combination of data
is not appropriate in such cases. In addition, the several formats and dimensions in
which data are produced can make simple merging not applicable and in some cases
impossible.
Here, we propose a conceptual framework for genomic data integration. In par-
ticular, we reconstruct an integrative model of genetic aberrations, miRNA and reg-
ulator genes that may explain expression levels in DLBCL. We first use the Module
Networks procedure to learn a model that associates modules of co-expressed genes
with 'regulatory programs' that use a combination of transcription factors and signal-
ing molecules. We further extend this approach to integrate other datasets, namely
miRNA expression and DNA copy-number information. In particular, the effect of
miRNAs on cell pathology and physiology is likely to be complex given the fact that
their activity is exerted in a one-to-many fashion (each miRNA can control transla-
tion of tens or even hundreds of different coding genes) and that a single gene can be
controlled by more than one miRNA.
Among other findings, our analysis associates miR152 and CD63 with survival,
links MYCBP and COPS5 with a module of genes enriched for oxidative phosphoryla-
tion and mitochondrial functions, and CREBL2 with a glycolysis module. The model
raises concrete testable hypotheses which can be tested by perturbation experiments:
for example, using RNA interference to interrogate whether decreased expression of
individual regulators alters the expression of target genes.
Overall, our analysis demonstrates the discovery potential of systems-level ap-
proaches and represents an essential component of a rational strategy for identifying
drug mechanisms and developing new diagnostic tests and therapeutic approaches.
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4.11 Figures and tables
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Figure 4-1: Analysis flow. Unsupervised reconstruction of transcriptional modules was
performed with the Module Networks algorithm using transcription factors and signaling
molecules as candidate regulators. The modules were utilized to study enrichment and
to search for regulation programs with miRNAs and copy number alteration profiles. The
results generate hypotheses about potential DLBCL drivers and genes associated with prog-
nosis.
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Figure 4-2: The average Bayesian Score per gene, as a function of module number, inferred
with the Module Networks algorithm. We chose 100 modules, the model whose Bayesian
score was 85% of the best score.
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Figure 4-3: Birdseye view of the 100 modules. The modules are shown as horizontal
strips (there are 100 such strips and thus 100 modules), and for each module, its samples
are shown sorted by the regulatory program with each split in the tree shown by separate
blocks separated by yellow lines.
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Figure 4-4: Global view of the 100 modules (rows) and 110 samples (columns) generated
with the Module Networks algorithm and hierarchically clustered; the heatmap presents the
average expression of the genes in each module in each sample.
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Figure 4-5: GISTIC Peaks. The statistical significance of the aberrations are displayed
as FDR q values to account for multiple-hypothesis testing. Chromosome positions are
indicated along the y axis with centromere positions indicated by dotted lines. The locations
of the peak regions are indicated to the right of each panel (amplification peaks 1 to 19 and
deletion peaks 1 to 26).
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Figure 4-6: Gene sets enrichment of modules (columns) highlighted in the main text.
Colors refer to the gene set source.
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110 samples into two groups. (B) Kaplan-Meier survival curve of samples partitioned in A.
Group showing CD63 induction has increased probability of death.
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of survival.
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' ' '., 'Top Regulator # genes
module
in # samples
side of split
# samples right
side of split
746 RAP2B 5 77 33 0.00011 0.0077
926 OPHNI 29 6 104 0.00016 0.0077
1075 CD63 39 69 41 0.00043 0.014
716 BCL6 55 64 46 0.004 0.1
1201 ZMYND11 25 60 50 0.0092 0.17
1011 PGF 16 30 80 0.011 0.17
MIR- 152
MIR-152
MIR-19b
MIR-27b
MIR-27b
MIR-223
MIR- 152
MIR-93
MIR-152
MIR-152
LET-7d
LET-7e
MIR-24
LET-7b
MIR-352
MIR-352
MIR-352
MIR-352
MIR-424
MIR-424
MIR-223
MIR-223
MIR-26a
MIR-26a
LET-7d
MIR- 140Star
LET-7b
MIR-93
LET-7d
LET-7d
10
28
23
24
18
38
14
5
25
44
32
18
39
25
64
53
128
25
13
7
32
37
49
47
40
46
19
29
57
44
65
70
13
78
78
51
68
41
69
69
71
37
48
52
64
64
64
44
42
42
67
67
51
51
44
47
71
16
56
72
18
13
70
5
5
32
15
42
14
14
12
46
35
31
19
19
19
39
41
41
16
16
32
32
39
36
12
67
27
11
0.0014
0.0028
0.0031
0.0035
0.0035
0.0089
0.013
0.0164
0.0168
0.0168
0.0235
0.0239
0.0279
0.0292
0.0328
0.0328
0.0328
0.0354
0.0402
0.0402
0.0435
0.0435
0.0486
0.0486
0.0522
0.0544
0.0584
0.067
0.0744
0.075
0.0696
0.0696
0.0696
0.0696
0.0696
0.147
0.166
0.166
0.166
0.166
0.1911
0.1911
0.1911
0.1911
0.1911
0.1911
0.1911
0.1945
0.1959
0.1959
0.1959
0.1959
0.2007
0.2007
0.2067
0.2071
0.2142
0.2369
0.2474
0.2474
Table 4.1: List of modules whose top regulator in
prognosis.
the regulatory program predicts survival
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Module ID
963
999
920
927
987
1123
1093
746
860
1249
1231
908
1075
1201
782
848
1099
1267
1105
1171
975
1081
854
933
1261
884
830
926
1057
788 I I ,
left P-value
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5.1 Summary
In this thesis we present several approaches to systematically reconstruct, validate
and refine a regulatory circuit. We take advantage of recent advances in genomics to
advance our understanding of the molecular mechanisms controlling gene expression
programs in dendritic cells and cancer.
In Chapter 2, we use gene expression data and knockdowns to reconstruct a func-
tional regulatory network in mouse dendritic cells exposed to various pathogens. Link-
ing gene expression to the response of a specific cell type after exposure to a pathogen
may facilitate therapeutic targeting of specific pathways to enhance human vaccine
efficacy or to combat the drivers of a disease. We first used microarrays to character-
ize transcriptional responses of dendritic cells to various pathogens at different time
points. Then, building on the framework of probabilistic graphical models and the
elastic net (LARS-EN) regression, we learned an observational model of gene regu-
lation, identifying candidate regulators that act on target genes. The expression of
these regulators was then reduced by > 75% using lentiviral small hairpin RNAs in
dendritic cells. Then, a gene expression signature was measured at a selected time
point, after exposure to a single treatment that activated many of the pathogen re-
sponses. The functional regulatory network reconstructed from these data agreed with
the observational model only to a certain extent. The large amount of false-positive
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interactions of the observational model is due to the fact that a correct regulator
had gene expression profiles that were indistinguishable from other regulators, a clear
shortcoming of models lacking functional approaches.
Each perturbation experiment associates a perturbed regulator with targets that
are repressed or induced by the perturbation. However, it is expected that these
include both direct and indirect targets. To distinguish those, we introduce in Chapter
3 the algorithm Exigo, used to 'prune' likely indirect interactions from perturbation
screens. We used a matrix representation of the network topology to evaluate the
number of self-avoiding random walks that can link a pair of connected nodes in
the original network constructed to describe a set of perturbation experiments. This
gives rise to a reference matrix that is used to generate a set of 'equivalent' networks
consistent with experiments. The method improves on currently available methods to
characterize parsimonious network topologies because Exigo can also analyze global
effects of edge removal in networks. Even though Exigo is not itself a network inference
procedure (but rather a method to distinguish direct from indirect interactions from
experimental screens), we show that combining it with a state-of-the-art network
inference method significantly improves inference results.
Lastly, in Chapter 4, we provide a system-level dissection of regulatory mecha-
nisms in tumorigenesis. In particular, we built a module network for diffuse large
B-cell lymphoma using multiple high-throughput assays (gene expression microar-
rays, DNA copy-number SNP arrays, and microRNA arrays) and clinical data. Our
analysis identified several modules enriched for functional categories and predicted
novel genes and microRNAs that have never been associated to this cancer type.
We are conducting an ongoing perturbation screen to confirm the functions of these
genes and provide a better understanding of how cellular networks are de-regulated
in DLBCL. Overall, this study expands the knowledge about causal and combinato-
rial relationships that characterize molecular signatures in DLBCL, and provides a
systematic approach for the integration and analysis of different types of datasets.
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5.2 Future perspectives
While our work advances the systematic reconstruction of regulatory circuits in mam-
malian systems, the computational approaches are still limited in several aspects.
Here, I will discuss these challenges and propose some directions for addressing them.
The initial observational model connects regulators to target genes based on linear
dependencies between their temporal profiles. The defining property of linear models
is that each regulator contributes to the input of the regulation function independently
of the other regulators, in an additive manner. That is, the change in the level of
each entity depends on a weighted linear sum of the levels of its regulators. Even
though this assumption has a high level of abstraction, it proved, in Chapter 2, to be
efficient in selecting regulators that were functional.
The perturbational dataset further allowed us to test the quality of the initial
observational model, revealing a lot of false positive interactions. This was mainly
due to the fact that a correct regulator had gene expression profiles that were in-
distinguishable from other regulators. This limited explanatory value shows that a
linear model is a crude description of the process of gene regulation. To leverage
the complementary power of both models, a possible next step could be to incorpo-
rate the interventional data in the learning method to refine the initial model. For
example, using a prior to favor edges that correspond to the experimentally iden-
tified interactions in the perturbation screen can lead to a more predictive network
[130]. Furthermore, genes which are affected differently by perturbations should be
more likely assigned to distinct modules, even if their expression profiles are similar,
whereas those with similar regulation may still be separated if their expression is
distinct. The refined model would then give rise to new hypotheses that could be
tested with other single-gene perturbation experiments or combinatorial ones. Itera-
ting this cycle would sequentially improve the model's resolution, providing a deeper
understanding of the specificity of the circuit.
The choice of candidate regulators in the observational model can be diversified
to expand the scope of regulatory circuits. mRNA profiles can assist in identifying
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candidate signaling proteins (e.g., [131]), chromatin factors, large non-coding RNAs,
or RNA-binding proteins. In addition, several other global profiling technologies could
be used in order to expand the circuit components to study, such as mass spectrometry
[132] for metabolite profiling and for measuring protein abundance, and ChIP-seq
[133] and HITS-CLIP [134] (also known as CLIP-Seq) to quantify protein-nucleic
acid binding.
The scale and quality of networks will improve significantly when large-scale per-
turbations are coupled with next-generation sequencing [50]. Multiplexed RNA-Seq
and ChIP-Seq approaches will allow thousands of transcriptomes to be directly linked
to genome-wide binding profiles of thousands of transcription factors. Then it will
be easier to discriminate direct from indirect gene regulation and to interpret net-
works in the context of additional mechanisms of RNA dependent regulation, in-
cluding microRNA binding and alternative splicing. However, the identification of
"non functional " and "redundant" binding is a remaining challenge. Linking predic-
tive networks to function will facilitate the translation of molecular interactions into
therapies.
Since many of the network interactions identified by gene knockdown are likely to
be indirect, we developed Exigo. This method identifies the interactions that are nec-
essary to explain a set of gene-perturbation experiments. Exigo can be extended be-
yond purely topological considerations by explicitly considering the confidence weights
associated with each interaction in the perturbation screen.
In Chapter 4, we present an unsupervised approach for integrating different types
of data. Our integration strategy consisted in examining a module of genes defined
by one data type in the context other data types. In fact, it is particularly difficult
to combine predictors from different date types in a simultaneous learning procedure
since their quality and informativity are usually different. The strategy that we
followed can be useful when the scope of genomic experiments performed is so diverse
that it is not immediately clear how, or even if, one experiment relates to another.
We showed that unsupervised integration can be a powerful discovery tool for finding
regulatory associations, which can then be experimentally validated. However, when
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we searched for regulatory programs of CNAs for the modules (of mRNA profiles), we
noticed that CNAs did not discriminate well between contexts of expression profiles.
This may be due to the fact that we were searching for regulatory programs of discrete-
value measurements to explain modules of real-valued measurements. Thus, it would
be useful to extend the regulatory program search to efficiently evaluate a set of
discrete-valued candidate regulators.
The scale and scope of studies made possible by perturbation screens, along with
the emergence and refinement of genomic, transcriptomic, and proteomic techniques,
are providing a system-wide understanding of gene networks in an increasing number
of specific cell types, tissues, and organisms. This holds great promise for the future
of network reconstruction. The unbiased, systematic and integrative approaches I
describe in this thesis show potential to enhance our understanding of biological
systems. These approaches are general and applicable to almost any biological system,
as well as practical for most laboratory settings, an important step that has broad
implications for the scientific community.
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